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Chapter 1:  
Introduction 
 
1.1 Breast Cancer and Pancreatic Cancer 
Cancer is the uncontrolled growth of abnormal cells in the body. Cancerous cells are also 
called malignant cells. About 1,638,910 new cancer cases are expected to be diagnosed in 
2012. In 2012, about 577,190 Americans are expected to die of cancer, which is more 
than 1,500 people a day. Cancer is the second most common cause of death in the United 
States. The five-year relative survival rate for all cancers diagnosed between 2001 and 
2007 is 67%, up from 49% in 1975–1977(www.cancer.org). This improvement in survival 
reflects both progress in diagnosing certain cancers at an earlier stage and improvements 
in treatment. Cancers that can be prevented or detected earlier by screening account for at 
least half of all new cancer cases. 
 
1.1.1  Breast Cancer 
Breast cancer is the second leading cause of death by cancer in women. The chance that 
breast cancer will be responsible for a woman’s death is about 1 in 36 (about 3%). Death 
rates from breast cancer have been declining since about 1990, with larger decreases in 
women younger than 50. These decreases are believed to be the result of earlier detection 
through screening and increased awareness, as well as improved treatment. 
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The American Cancer Society’s most recent estimates for breast cancer in the 
United States are for 2012: about 226,870 new cases of invasive breast cancer will be 
diagnosed in women. 
Approximately 63,300 new cases of carcinoma in situ (CIS) will be diagnosed 
(CIS is non-invasive and is the earliest form of breast cancer), and 39,510 women will die 
from breast cancer After increasing for more than two decades, female breast cancer 
incidence rates began decreasing in 2000, then dropping by about 7% from 2002 to 2003. 
At this time there are more than 2.9 million breast cancer survivors in the United States. 
(This includes women still being treated and those who have completed treatment.)  
 
1.1.2  Pancreatic Cancer 
In 2012, about 43,920 people (22,090 men and 21,830 women) will be diagnosed with 
pancreatic cancer. Approximately 37,390 people (18,850 men and 18,540 women) will 
die of pancreatic cancer. Since 2004, rates of pancreatic cancer have increased about 
1.5% per year. The lifetime risk of developing pancreatic cancer is about 1 in 71 (1.41%). 
This is about the same for men and women. 
 
1.2  Optimism and Anxiety in Breast Cancer 
Anxiety and depression have been identified as a common psychological distress faced 
by the majority of cancer patients. With the increasing number of cancer cases, increasing 
demands will be placed on health systems to address effective psychosocial care and 
therapy. According to the most recent estimates, around 85% of women diagnosed with 
breast cancer will live to be long-term survivors. This, coupled with the advancements 
3 
being made from researchers and scientists working year-round to develop innovative 
and more effective methods of treatment, means that there is a lot for breast cancer 
patients to be optimistic about in 2012 (Achieve Clinical Research, 2012). 
 
1.3  Kernel Density(Non-Parametric Method ) 
It is possible to identify the probability distribution of survival analysis and characterize 
behavior of survival time incorrectly, or it is possible for the goodness-of-fit test 
methodology to fail to classify a classical probability distribution. Thus, proceeding with 
the survival analysis in this way may result in misleading and incorrect results. One of the 
methods is based on estimating failure density through the concept of distribution-free 
kernel density method. 
Let t1, t2… tk be independent and identically distributed samples of a random 
variable, and then the nonparametric probability kernel density estimate  ̂    is written as  
 ̂     
 
  ̂
∑   
    
 ̂
 
    , 
where K is the kernel and  ̂ is the estimate of the optimal bandwidth. 
To obtain the best kernel density estimation (KER), combinations of different 
kernels and optimal bandwidths were tested. The best of all experimental results was a 
kernel,                                     
 
 
             (|y|≤ 1) 
with                                     ̂  
               
      
 
 
 
      . 
The kernel density of survival function is given by 
 ̂ ̂    ∑
 
  ̂
∑    
    
 ̂
 
        , 
where the K is the kernel and  ̂ is optimal bandwidth. 
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  ̂    
 
  ̂
∑   
    
 ̂
 
    
   ∑
 
  ̂
∑   
    
 ̂
 
       
 
 
1.4  Survival Analysis 
Survival analysis is a collection of methods for the analysis of data that involves the time 
to occurrence of some event. Scientists have established different methods of probability 
survival analysis—parametric, nonparametric, and semi-parametric—to approach a 
statistical analysis of data. Scientists have used a variety of parametric functions to 
approximate the distribution of survival times of a patient who survived cancer under 
study.  
Mathematically, the survival function is defined as follows: 
                ∫        
 
 
    (t ≥ 0), (1.1) 
where T denotes the survival time of event and  (T ) is the failure probability 
distribution.  
It is likely that the study is often terminated before the death of all patients, and it may be 
considered that some patients were still alive at the end of the study, disregarding when 
they really became deceased. This case is called right censored data. 
         Not always an effective distribution-free procedure to characterize the probabilistic 
behavior of the failure data can be identified as those from a classical probability 
distribution. For this reason, in this study, we will compare all these methods by 
evaluating the Kaplan-Meier (KM), the Cox Proportional Hazard (Cox PH), and the 
Kernel density (KER) methods to propose the best approach to survival analysis to 
identify the best estimator function for probabilistic distribution survival function. 
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A different approach to standard parametric survival analysis that extended the 
methods of the non-parametric Kaplan-Meier estimates to regression-type arguments for 
life-table analyses was performed by David Cox in 1972.  
 
1.4.1 Kaplan-Meier Method 
The Kaplan-Meier analysis is used to analyze how a given population evolves with time. 
This technique is mostly applied to survival data and product quality data. There are three 
main reasons why a population of individuals or products may evolve: some individuals 
die (products fail), some go out of the surveyed population because they get healed 
(repaired), or their trace is lost (individuals move from location or the study is terminated, 
among other reasons). The first type of data is usually called “failure data,” or “event 
data,” while the second is called “censored data.” The probability that an item from a 
given population will have a survival time exceeding t is the survival function, S (t). Let 
us consider a random sample size k of the failure observed times until death, that is t1, t2, 
t3, …, tn, such that t1≤ t2 ≤ t3 ≤ …, ≤tk-1≤ tk, where n j is the number of patients at risk just 
prior to time t j, and let d j be the number of deaths at exactly time t j. 
Survival function can be estimated directly from the continuous survival failure 
times. Naturally, a life table can be created by each time interval that contains exactly one 
case, multiplying out the survival probabilities across the “intervals” (i.e., for each single 
observation). The survival is given by the function 
   ̂    ∏
     
  
        , for t 1 ≤ t ≤ t k , (1.2) 
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 where the estimated survival function     ̂    is either 1 if the jth case is uncensored 
(complete), and 0 if it is censored. The estimate of cumulative Hazard function is given 
by  
   ̂              (1.3) 
 
1.4.2  Cox Proportional Hazard Model 
Cox advanced to prediction of survival time by making no assumptions about the 
baseline hazard of individuals and only assumed that the hazard functions of different 
individuals remained proportional and constant over time. In the equation 
 ̂             ( ̂      ̂        ̂    )  (1.4)  
ho (t) is the baseline hazard function, β’s are regression coefficients, and xi denotes an 
individual covariate vector (explanatory variable). 
This model is a semi-parametric estimation because, while the baseline hazard can 
take any form, the covariates enter the model linearly. The survival function as a result of 
Cox PH performance is given by   
              ∫      
 
 
   .  (1.5) 
That is, the influence of variables is to shift the baseline survivor function 
 
                      (1.6) 
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Chapter 2: 
Optimism and Breast Cancer 
 
2.1 Introduction 
Breast cancer is the most common cancer in women, no matter their race or ethnicity, and 
it is the second most common cause of death from cancer among white, black, Asian-
Pacific Islander and American-Indian Native women. An estimated 192,370 new cases of 
invasive breast cancer were diagnosed in 2009, and only 62,280 additional cases were in 
situ breast cancer. According to the National Cancer Institute, approximately 40,170 
women died from breast cancer in 2009 (www.cancer.org). 
Optimism is an expectation of good outcomes in life, rather than bad outcomes. 
An optimistic person directly deals with stress and anxiety by seeking information, 
planning options. Carver et al. (2005) found that “the optimism presenting in the first 
year after surgery predicted adjustment 5–13 years later, even after controlling for earlier 
adjustment.” Carver et al. (2005) further stated that “optimism is a significant predictor of 
physical and psychological functioning in patients suffering from various medical 
conditions.” In 1999, Epping-Jordan et al. found that, at diagnosis and at a six-month 
follow-up, symptoms of anxiety and depression were predicted by low dispositional 
optimism. Optimism is considered as having hopefulness and confidence about the future 
or believing in a successful outcome of something (Carver, 2005). 
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Optimism is the key to coping with health-related stress, strategies, and outcomes 
(Carver et al., 2005). Much of the long-term increase in incidence may be attributed to 
variables that can change the rate of breast cancer death, such as optimism (Allison, 
Guichard, Fung, & Gilain, 2003).  
The data in this study were collected in the breast surgery clinic of an urban 
hospital by Dr.Lauver and Dr. Tak from university Wisconsin. Participants were seeking 
evaluation for self-identified breast cancer symptoms, such as a lump or discharge. 
Eligible participants were older than 18 years of age, had no personal history of cancer, 
and could communicate in English. The sample was 135 participants aged 19 to 76 
(Lauver & Tak, 1995). 
Optimism: Outcomes of the patients’ actions were reflected by how optimistic 
they were. The LOT (Life Orientation Test) measures optimism by indicating the extent 
of a person’s agreement using 10 items, where each item is scaled from zero (strongly 
disagree) to 4 (strongly agree). Also, the revised scale was constructed in order to 
eliminate two items from the original scale, which dealt more with coping style than with 
positive expectations for future outcomes [Appendix 1].   
Education: The data include the education levels of 135 patients, coded from 
zero (less than eighth grade completed) through 7 (doctorate degree earned). For instance, 
code 3 represents having a high school diploma.  
Care-Seeking Delay: Care-seeking delay is defined as the number of days 
between finding a symptom and initially contacting a health care provider. That contact 
was defined as either making a call for an appointment or going in for an evaluation.  
Age: The cancer patients were aged 19 to 76. 
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This present study was conducted in response to the article “Optimism and 
Coping with a Breast Cancer Symptom,” which was published by Diane Lauver and 
Young Ran Tak in 1994.  
Lauver and Tak in their investigation of breast cancer and effect of optimism 
intended to answer these questions:  
 Whether there is the influence of optimism on delay or anxiety mediated 
either through expectations of seeking care with a breast symptom or through perceived 
likelihood of breast cancer. In addition, the hypotheses were tested in their study to show 
whether any significant correlation existed between optimism, expectations of care-
seeking, likelihood of cancer, anxiety, delay, age, race, education, occupation, and 
income (Lauver & Tak, 1995). Also, they included a regression model between the 
optimism and independent variables by results of significant correlation.  
 In our study, for the data available to us, we performed the correlation matrix by 
calculating a correlation coefficient 
     = 
 ∑      ∑     ∑   
√ ∑  
   ∑   
 √ ∑  
   ∑   
 
 , (2.1) 
which is a measure of the strength and the direction of a linear relationship between two 
variables, where n is sample size, and     and    are information variables. Statistical 
inference based on Pearson’s correlation coefficient aims to test the null hypothesis that 
the true correlation coefficient of population ρ is equal to 0, based on the value of the 
sample correlation coefficient r ; H0: ρ = 0 vs. Ha: ρ ≠ 0, which the conversion of r to a 
student’s t-distribution is defined by 
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   = 
 √   
√    
 , (2.2) 
with the degree freedom of d. f. = n-2 (Rodgers & Nicewander, 1988) . The results of the 
correlation coefficient matrix are shown in Table 1.1. Also, we considered a level of 
significance α= 5% for the test hypothesis and a non-significant p-value < .05, as there is 
a random, nonlinear relationship between the two variables. In other words, correlation 
does not imply causation; correlation can be a hint. 
Lauver and Tak in their results of the correlation matrix found that Lot-scores 
were related inversely to delay and anxiety and that there was a positive relation with 
expectations of care-seeking (Lauver & Tak, 1995). However, their results showed that 
there is not a significant linear relationship between delay, expectation of care-seeking, 
and anxiety because the p-value > 0.05. Thus, they omitted the clinical factors from their 
Table 2.1 and subsequent analyses.    
Our study implies an inverse association between Lot-scores and delay with the 
correlation coefficient  ̂ = -0.19, which is almost the same as theirs, and p-value = 
0.0238, which is p-value < 0.05.  
Moreover, we performed a nonlinear relationship between Lot-score and delay, which 
will be shown in section 5.1. Because of our results, also, we suspect a nonlinear 
association between optimism and the expectation of care-seeking and anxiety. We could 
not perform regression models for these variables because all the necessary information 
was not available to us. 
 
 
 
  
 
11 
Table 2.1 Correlation Table of Attribute Variables 
 
Correlation Coefficients, N = 135 
 
                                                      Transformed 
                                Lot-score    -delay      Age        Education    Race 
 
Mean 
 
Standard 
deviation 
 
 
Lot-score 
 
Transformed
-delay 
P-value 
 
Age 
P-value 
 
Education 
P-value 
 
Race 
P-value 
 
 
1.00000       
 
-0.17736       1.00000        
 
0.0396 
 
0.16298       0.05783     1.00000   
0.0589         0.5053                     
 
0.31548     -0.11152     -0.12108   1.00000     
0.0002          0.1978        0.1618                        
 
0.21572     -0.10834    0.07025      0.35220       1.0000 
0.0120        0.2110        0.4181       <.0001 
 
 
2.5400 
 
 
2.9170 
 
 
 
37.3407 
 
 
3.1852 
 
 
 
0.72752 
 
 
1.8815 
 
 
 
12.3338 
 
 
1.3169 
 
 
 The Lauver and Tak study showed that regression models among optimism, 
expectation of care-seeking, and anxiety were performed because of the significant 
correlation between these variables. Regressing anxiety based on optimism alone was 
revealed with the regression coefficient ̂= -0.23 and p-value < 0.01. Regressing anxiety 
based on expectations and optimism was found to be non-significant with  ̂= - 0.11, p < 
0.20. The authors found that their results of regressions supported an indirect effect of 
optimism on anxiety, as mediated through expectations of care-seeking. Our results could 
not confirm their results because the necessary data were not available in this region. 
 In their results, optimism correlated positively to education and occupation 
levels of the white race. Regressing delay on optimism was revealed with β = -0.18, p-
value < 0.05. Controlling for occupation, β = -0.16, p-value = 0.07; for education β = -
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0.15, p = .09; for all three factors of education, occupation levels, and race together was a 
non-significant β = -0.11, p > 0.01. In our study, a regression model, a scatter plot of y 
(optimism) against x (independent variable) is designed. The scatter plot for all breast 
cancer patients is suggested in the following model, which is a linear model of  ̂   ̂  
 ̂  + ε   where   is the explanatory variable, and  ̂ and  ̂ are the constant regression 
parameters that are calculated by  
  ̂   
 ∑       ∑  ∑  
 ∑  
    ∑   
    (2.3) 
and  
   ̂   ̅   ̂ ̅    (2.4) 
and ε is the random variable disturbance (or error) that models the deviations from the 
straight line. Moreover, if there is a non-significant correlation, a nonlinear regression 
model, which is a mathematical model, is regressed. For instance, in section 2.5, we will 
show a nonlinear regression model between optimism and ages and for each race. 
Our regression model of optimism and education shows the regression coefficient 
 ̂ = 0.17 and p-value < 0.001, which does not support a negative regression coefficient  ̂ 
= -0.15 of Lauver and Tak’s regression result [(Lauver & Tak, 1995). 
 The results of our study verify that the mean of optimism is different among 
races. Thus, the regression models between optimism and education are found to be 
different for each race—a linear model for whites, and an exponential model for African 
Americans. 
Moreover, in section 2.6 of this present study, a mathematical model is regressed, 
which displays an indirect nonlinear relationship between delay and education in a 
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similar way for each race. Because of our results, we believe there will be an indirect 
relationship between delay and occupation levels for each race. 
 In a similar manner, Lauver and Tak regressed anxiety on optimism, 
controlling for education, occupation, and race individually. In these regressions, the 
relationship of optimism to anxiety remained essentially the same, β = -0.23, -0.25, or       
-0.26, p-value < 0.01, and controlling for all three factors together, β = -0.27, p-value 
<0.01. In this region, because information was not available, we could not regress the 
models. However, because of our results for optimism with other attributed variables, we 
could consider an opposite association between anxiety and optimism. 
 Next, in section 2.7, we will identify the mathematical model for optimism, 
delay, race, education, and age (the only accessible information) and their interactions for 
each race, as optimism is a function of attribute variables such as delay, race, education, 
economic status, religion or beliefs, occupation, likelihood of cancer, expectations of 
care-seeking, income, etc.,      =   (Delay, Anxiety, Race, Age, Education, Economic 
Status, Belief, Occupation, Likelihood of Cancer, Expectations of Care Seeking, 
Income…). 
 Moreover, in section 2.8, we investigate the probability distribution that 
characterizes the optimism for the African-American race, the white race, and both 
together. 
 Finally, in this present study we will use the subject data to perform a more 
precise and relevant analysis of the delay with respect to breast cancer. More specifically, 
we will statistically address the following basic questions on the subject matter: 
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 Is there any relationship between delay as a key response and independent 
variables such as education and age with respect to each race? 
 Is there any relationship between delay, education, and age with respect to each 
race? 
 What is the probability distribution that characterizes the delay for the African-
American race, the white race, and both races together? 
 
2.2  Data Review  
As the tree diagram below shows (Figure 2.1), the135 participations have a statistical 
mean of optimism of 2.54, age of 37.3407 years, delay of 94.2593 days, and education at 
level 3.1852. 
 
 
Figure 2.1 Optimism of Breast Cancer Data Diagram 
 
Optimism 
Mean=2.54 
Std-Dev=.7275 
Education 
Mean=3.1852 
Std-Dev=1.3169 
Age 
Mean=37.3407 
Std-Dev=12.3338 
Delay 
Mean=94.2593 
Std-Dev=264.1864 
  
 
15 
The data include two races: 52.6% African Americans and 47.7% whites, for which the 
graph below shows basic statistical information for each race with respect to the 
independent variables of education, delay, and age [Figure 2.2].  
 
Figure 2.2 Optimism of Breast Cancer Data Diagram of Races 
 
2.3  Comparison of the Mean of Optimism among Races 
To compare the difference between the mean optimism between races a nonparametric 
test, Kruskal-Wallis is performed to support our parametric t-test. The notations μ AA and 
μ w are used to represent the true population mean of optimism for white females and 
 
Optimism 
Mean=2 .54 
Standard dev=.7275 
 
White (64) 
MeanOpt=2.7047 
Education 
Meanedu=3.6719 
Delay 
MeanD=72.2031 
Age 
Meanage=38.25 
African-American 
(71) 
MeanOpt=2.3916 
Education 
Meanedu=2.7465 
Delay 
MeanD = 114.1409 
Age 
Meanage=36.5211 
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African American females respectively (Dancey & Reidy, 1952). The results are shown 
in Table 2.2 below.  
Table 2.2 Test Hypothesis for α= 5% Significance Levels for Mean of Tumor Size 
Significance Level of  α = 5% P-value 
H0:     μ AA = μ w vs.   H1:  μ w  > μ AA 0.0085 
 
Thus, the mean of optimism between races is significantly different in favor of the 
whites, with greater optimism at α = 5% level of significant with a p-value < 0.0085. 
Also, a parametric t-test supports the current decision. In addition, the analysis reveals 
that the mean of optimism of the white females is larger than the African-American 
females. 
 
2.4  Statistical Analysis and Modeling 
2.4.1 Education Levels and Optimism 
The data include the education levels of 135 patients, coded from zero (less than eighth 
grade completed) through 7 (doctorate degree earned). For instance, code 3 represents 
having a high school diploma. The means of optimism by levels of education are shown 
in Table 2.3 below. It is observed that the mean of optimism is increased by increasing 
the level of education. 
 Also evident is that the highest relatively frequency of education was in the ranks of 
level 3 with 30.37% (high school diploma) and level 2 with 24.44% (higher than eighth 
grade) and the lowest incidence is at level 7 with 3.5%.  
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Table 2.3 Frequency, Mean, and Standard Deviation Education Levels for Races 
Education  Frequency      Mean        Minimum       Maximum      Std-Dev         
Levels         
 1               11                  2.2363636   1.4000000     3.6000000   0.6960930  
 2               33                  2.3818182   1.2000000    4.0000000    0.6521381 
3                41                  2.4146341   1.0000000    3.8000000    0.6582404 
4                29                  2.7000000   1.2000000    3.9000000    0.7540368 
5                13                  2.8615385   0.6000000    4.0000000    0.9004984 
 6                7                   3.1000000   2.4000000    3.9000000     0.5477226 
 7                1                   3.5000000   3.5000000    3.5000000         . 
 
It is observed that the mean of optimism among races in almost all education 
levels is higher in whites than in African Americans. As shown below in Table 2.4, a 
direct relationship exists between the mean of optimism and education for white breast 
cancer patients. However, a direct association is not perceived between education and 
optimism for African Americans Table 2.4 and model 2.6.   
      
Table 2.4 Education Levels by Mean and Standard Deviation of Optimism for Each Race 
Race Education Levels 
 
                          1               2            3          4              5              6              7 
 
AA 
 
 
 
 
 
White 
Frequency 
Mean 
Std-Dev 
10 
2.2600 
0.7290 
23 
2.4000 
0.7168 
 
19 
2.3263 
0.6401 
 
14 
2.5071 
0.5850 
 
4 
2.4500 
1.3772 
 
1 
2.9000 
0.0000 
0 
0.0000 
0.0000 
Frequency 
Mean 
Std-Dev 
1 
2.0000 
0.0000 
10 
2.3400 
0.5038 
22 
2.4909 
0.6789 
15 
2.8800 
0.8645 
9 
3.0444 
0.6187 
6 
3.1333 
0.59217 
1 
3.5000 
0.0000 
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 2.4.2 Mathematical Model for Optimism and Education Levels         
Our results are established a statistical model of optimism levels by education ranks, 
which implies a direct relationship between the mean of optimism and education in breast 
cancer patients. In this model,  ̂ represents optimism and   is the education variable 
   ̂ = 1.93145+ 0.20265 ,  (2.5) 
 where R-square = 0.95, mean square error=0.01230, adjusted-R = 0.93 (Figure 2.3). 
 
Figure 2.3 Graph of Actual Value and Predicted Value of Mean Optimism vs. Education 
 
Our results are shown that the races had different mathematical models with 
respect to mean of optimism by education levels. The African Americans’ model   
   ̂ =2.3279 + 0.00139     + ε,  (2.6) 
where R-square = 0.89, mean square error = 0.0069, and adjusted-R = 0.87.  
For whites, the optimism model is given by  
   ̂ =1.82121 + 0.23715x + ε,  (2.7) 
lotscore
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         2.2
         2.3
         2.4
         2.5
         2.6
         2.7
         2.8
         2.9
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         3.3
         3.4
         3.5
education
1 2 3 4 5 6 7
Mean Optimism VS. Education for All
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where R-square = 0.98, mean square error = 0.0067, and adjusted-R = 0.98. Moreover, in 
all models, variables  ̂ and x represent the mean of optimism and education levels 
respectively, as shown below in Figures 2.4 and 2.5. 
 
Figure 2.4 Graph of Mean of Optimism vs. Education for African Americans 
     
 
Figure 2.5 Graph of Mean of Optimism vs. Education for Whites  
 
2.4.3 Summary of Optimism vs. Education 
Optimism has a positive relationship with education that is observed in all three models. 
The statistical model of optimism for all patients is increasing when the education levels 
are increasing. However, the mathematical models for races are different from each 
other’s, where African Americans’ is an exponential model and whites’ is a linear model. 
lotscore
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Finally,  it possible to estimate the score of optimism for each patient by knowing the 
level her of education.  
 
2.5  Age 
2.5.1 Optimism by Age 
As can be observed in Figure 2.6 below, there is no pattern of a mathematical model 
between optimism and age. 
   
Figure 2.6 Optimism (Lot-score) vs. Age 
To have a clear observation of the ages over optimism, the ages are divided into four-
year interval ages. A statistical mean of optimism for all ages in each interval is taken. 
For instance, in the four-year age interval 42 to 45 years, the age of 43.5 years is chosen 
to represent this interval, with a statistical mean for optimism of 2.762, as shown in Table 
2.5 below. As the table shows, 77.78% of patients are aged 19 to 45, and 20% range from 
l o t s c o r e
0
1
2
3
4
Ag e
1 0 2 0 3 0 4 0 5 0 6 0 7 0 8 0
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ages 46 to 69, and the lowest percentage of patients’ age is about 3%, from 70 to 76 
years. Also, as observed from the table above, the most optimistic patients are aged 54 to 
57, and the lowest aged 70 to 74. Moreover, it observed that among all patients, those 
aged 38 to 61 are more optimistic than those at the other ages.  
Table 2.5 Frequency of Age 
Age 
 
19.5 
23.5 
27.5 
31.5 
35.5 
39.5 
43.5 
47.5 
51.5 
55.5 
59.5 
63.5 
67.5 
71.5 
75.5 
Mean                 Std-Dev        Frequency     Percent         Cumulative 
Percent 
 
2.4142857 
2.5066667 
2.2809524 
2.4285714 
2.2666667 
2.7875000 
2.7615385 
2.5666667 
2.9700000 
3.0500000 
2.7250000 
2.2000000 
2.4000000 
2.1000000 
2.6000000 
 
 
0.6148945 
0.6017435 
0.6652962 
0.8718617 
0.5314360 
0.6119641 
0.7599764 
0.6889606 
0.7958922 
1.0344080 
1.2120919 
0.4242641 
      0.0000 
0.1414214 
0.0000 
 
 
7 
15 
21 
21 
12 
16 
13 
6 
10 
4 
4 
2 
1 
2 
1 
 
 
5.19 
11.11 
15.56 
15.56 
8.89 
11.85 
9.63 
4.44 
7.41 
2.96 
2.96 
1.48 
0.74 
1.48 
0.74 
 
 
5.19 
16.30 
31.85 
47.41 
56.30 
68.15 
77.78 
82.22 
89.63 
92.59 
95.56 
97.04 
97.78 
99.26 
0.0000 
 
2.5.2 Mathematical Model for Optimism and Age 
A mathematical model is attempted to determine optimism for the third variable of age. 
First, a graph of optimism versus ages is plotted; however, it does not observe any linear 
or nonlinear patterns of a mathematical function, as can be seen in the graph below, 
Figure 2.7.  
To get the best mathematical model of optimism versus ages, the ages are divided into 
different intervals, such as two years, three years, and four years. 
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Figure 2.7 Mean of Optimism vs. Age 
 
A statistical mean of optimism for all ages in each interval is taken. For instance, in the 
interval of four years for ages 42 to 45 years, the age of 43.5 years is chosen to represent 
this interval, with a statistical mean for optimism of 2.762, which it is observed in Table 
2.9.  
In all attempts’ models, the best mathematical model was arrived at in the interval 
of four years by reviewing our observation of graphs and analysis of the mathematical 
models [Figure 2.8]. In the interval of four years, we divided ages into two parts, one 
from 19 to 57 years, which included 93% of data information on age, and the second 
from 58 to 76 years, which contained 7% of the data. 
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Figure 2.8 Mean of Optimism vs. Four-Year Interval of Ages 
 
For each interval, it can be observed that in the different mathematical models, one is a 
nonlinear equation and the other is an exponential equation. It is established that the 
optimism model is for equal or less than 57. 
The mathematical model for optimism for ages less than and equal to 57 is as 
follows: 
  ŷ =15.12840 + 4.84417  ½ - 12.6418 ⅓ , (2.8)
 
 
with R-Square = .7386 and mean of residual = 0, standard deviation-residual = .141271, 
sum residual = 0, sum-square-residual = .17962, and press = .29911 when ŷ represented 
as optimism and x implied the age.  
 Model of optimism for ages greater than 57:  
  ŷ =-1.74314+.05882 ,  (2.9) 
OPTI MI SM VS.  AGE  1 3 5  b r e a s t  c a n c e r  c a s e
Op t i mi s i m
1 . 0
1 . 5
2 . 0
2 . 5
3 . 0
3 . 5
4 . 0
a g e
1 5 2 0 2 5 3 0 3 5 4 0 4 5 5 0 5 5 6 0 6 5 7 0 7 5 8 0
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 where ŷ and x represent the mean of optimism and age, respectively. The equation had 
an R-Square of 73% with a mean of residual of 0 and a standard-Residual of .049. Figure 
2.9 displays a graph of estimated value and mean actual value of optimism vs. age 
 
 
Figure 2.9 Predicted Value of Optimism vs. Age (•) and Actual Optimism Data (*) vs. Age 
 
2.5.3 Optimism vs. Age with Respect to Race 
With regard to race, the mean of optimism was significantly different as a result of 
nonparametric and parametric tests. A separate mathematical model was discovered for 
each one, which emphasized the modeling for ages 57 years or younger, as more than 
80% of the data were in this interval. For African-Americans, 
  ŷ = -338.43258 -15.421542 +215.97692  1/3 - 0.17718x2- .00101 3 , (2.10) 
 where R-Square = 0.7889 and sum residual = 0.0, sum-square = 0.18002, press = 1.72, 
when ŷ represents the mean of optimism and x is age. Model of optimism for ages greater 
than 57:  
OPTI MI SI M VS.  AGE  1 3 5  b r e a s t  c a n c e r  c a s e
l o t s c o r e
2 . 2
2 . 3
2 . 4
2 . 5
2 . 6
2 . 7
2 . 8
2 . 9
3 . 0
3 . 1
a g e
2 0 3 0 4 0 5 0 6 0
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ŷ = -1.65804+ 0.05815 ,               (2.11), 
where R-Square = 0.72, sum residual = 0, sum-square = 0.24577, and press = 0.88845, 
when ŷ represents the mean of optimism and x is age; for Caucasians, 
ŷ =262.44122 +-21.51466x-138.97148 x ½ - 0.18910x2- .00096130 x3 , (2.12) 
where R-Square = 0.9077, sum residual = 0, sum-square = 0.07716, and press = 0.33277, 
when ŷ represents the mean of optimism and x is age. Model of optimism for ages greater 
than 57:  
ŷ =1.93063+ 4.26033E26 exp (- ),     (2.13), 
where R-Square = 0.76, sum residual = 0, sum-square = 0.4028, and press = 4.52266, 
when ŷ represents the mean of optimism and x is age. 
 
2.5.4  Summary of Optimism vs. Age 
The mean of optimism for both races, with respect to two groups of age by intervals of 
four years, were different and had dissimilar mathematical models. For participants aged 
57 years or younger, the rate of optimism increased with slow rhythm, and for those older 
than 57 years, the rate decreased. Both races had a nonlinear mathematical model in the 
interval age younger or equal to 57 years old. 
 
2.6  Optimism and Delay in Care-Seeking 
2.6.1 Delay-Care-Seeking 
The Delay in Seeking Care is the number of days between observing a symptom and 
searching for any medical aid. The delay is related to attribute variables such as 
optimism, race, education, age, economic, religion or beliefs, and …, 
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 delay= f(Race+ Age + Education+ Economic + Belief + …) 
 
2.6.2  Delay, Education, and Race 
50% of breast cancer patients contacted medical professionals within less than 15 days of 
delay in care-seeking.19% of patients with 1 or 0 days of delay have the highest 
frequency in delay days. The mean of delay with respect to race for African Americans is 
larger than that of whites. The mean of delay in care-seeking of African Americans is 
about 3 months and 24 days; for whites it is 2 months and 12 days. The zero-days of 
delay for African Americans is 8.45%, and the 84 months is the highest number for 
months of delay. Also, for African-American patients (59.15%) of had delays of less than 
one month, and 21.28% of them had more than 6 months of delay; whites are at 23.44% 
for less than one day of delay, and 37 months and 6 days is the highest delay for this race. 
60.59% of whites have less than 1 month of delay, and 7.81% of them have more than 6 
months of delay. 
 
2.6.3  Delay, Education Levels, and Race 
The processes of delay and education emphasized again that education is one of the most 
important keys of knowledge, since, by increasing the level of education, the mean of 
delay decreased [Table 2.6].Note that the level of seven was excluded since it was 
outliers. The results of delay by education with respect to races are shown for African 
Americans; the highest mean of delay is about 6 months at a level 3 education; whites are 
at 5 months at a level 2 education. In most cases for whites, by increasing the levels of 
education, delay decreased. 
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Table 2.6 Mean of Delay and Education for Both Races 
Education    Frequency      Mean          Std- Dev          Minimum       Maximum 
 
     1                   11       3.2636364         2.1077347           0                  6.30000     
     2                   33       3.0818182         1.8443248           0                  6.9000000 
     3                   41       2.9000000         1.9032866           0                  7.8000000 
     4                   29       2.9655172         1.9359892           0                  6.6000000 
     5                  13        2.6153846         1.7869183           0                  5.6000000 
     6                    7       1.9714286          1.9516782           0                 4.7000000 
     1                    1       3.5000000           0.0000000          0                  3.50000000 
 
However, for African Americans, the level of education did not follow the same results as 
whites.  
Table 2.7 Mean of Delay and Education for Africans Americans and Whites 
 
 
Race 
Mean of Delay-Care-seeking and Education Levels 
 
1               2              3           4              5               6              7 
 
AA 
 
 
 
 
 
 
White 
Frequency 
Mean 
Std-Dev 
10 
3.3667 
6.0966 
23 
1.9841 
2.4239 
19 
6.0614 
19.1633 
14 
4.7048 
6.9105 
4 
2.4417 
4.2450 
1 
0.0333 
0.0000 
0 
0.0000 
0.0000 
Frequency 
Mean 
Std-Dev 
1 
4.7000 
0.0000 
10 
4.8067 
9.811 
22 
2.8061 
7.8544 
15 
1.2844 
1.9574 
9 
1.3704 
2.0672 
6 
1.1444 
1.6207 
1 
3.0500 
0.0000 
 
Descriptive information about mean of delay and education is shown in the Table 2.7. 
 
2.6.4  Mathematical Model of Delay, Education, and Race 
The analysis of developing a mathematical model for delay versus education implies a 
cube relationship between them. In this model  ̂ represents delay and x is the education 
variable that is shown in the graph below, Figure 2.10. 
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Figure 2.10 Graph of  Mean of Delay vs. Education for All Participations 
 
The model of delay by education for both races is given by 
   ̂ = 3.20528 - 0.00502 3 ,    (2.14) 
where R-sq = .9445, Adjusted- R-Square = 0.9307,  F-Value = 68.11, P-value > F .0012, 
Mean residual = 0, Standard deviation-Residual = 0.10805, sum-residual = 0, and Sum-
square-Residual = .05836, and press = 0.16290. 
The mathematical model of delays vs. education levels for African Americans is 
followed by a third-degree polynomial race that is shown in the graph below [Figure 
2.11]; 
   ̂ = 4.61266 - 0.45818  3 ,  (2.15) 
where R-Square = 0.7331, Adjusted- R-Sq = 0.6664, Sum residual = 0,       
Sum-Square-Residual = 1.35131, and Press = 6.1486. 
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Figure 2.11 Graph of Delay vs. Education for African Americans 
 
For whites, the mathematical model of delay vs. education levels was followed by an 
exponential model that is shown in Figure 2.12; 
  ̂ = 2.31704 - 7.1518     ,  (2.16) 
 where  ̂ and   represent delay and education respectively. Also, the analysis of residual 
was R-Sq = .9358, Adjusted- R-Sq = .9143, F-value = 219.87, P-value < 0.0001, Mean 
residual = 0, Std-Re = .136656, and Sum of errors = 0.0000. 
 
Figure 2.12 Graph of Delay vs. Education for Whites 
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To search for more details about the connection of the mean of optimism and the mean of 
delay, the mean of delay is established by the four interval levels of optimism, as shown 
below in Table 2.8. 
Table 2.8 Mean of Delay by Four Levels of Optimism 
Optimism Interval 
Race 
(0 1] (1 2] (2 3] (3 4] 
African American 5.3 3.1778 3.1692 2.6178 
Whites 3.1 3.9500 2.3921 2.0104 
Both races 4.2000 3.5156 2.9365 2.3573 
 
 
It has shown in table2.8 that as the interval level of optimism increases, the mean of delay 
decreases, which implies an inversely direct relationship between the level of optimism 
and the mean of delay. 
 
2.6.5  A Mathematical Model of Optimism and Delay 
To find the best model of optimism versus of the mean of delay in care-seeking, delay 
data is transformed by week, month, and year. The best result observed the mathematical 
model of the mean of optimism with respect to the mean of monthly delay. 
For more than a seven-month delay, the model is 
  ŷ = - 4.08373 +1045.696     +3.75509  3, (2.17) 
and for the interval of seven months or less, the polynomial with degree of two, 
 ŷ = - 0.31438 x2+.39039 x+2.64618,  (2.18) 
where R-square = 0.9610, Sum of Residuals = 0.0, Sum of Squared Residuals = 0.00847 
and Predicted Residual SS (PRESS) was 0.17950. 
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2.6.6  Conclusion  
 Races with respect to delay had different distributions and different models. The mean of 
delay had a direct association with respect to education; by increasing education, the 
mean of delay decreases. Moreover, it is shown that the mean of delay decreases by 
increasing the mean of optimism. In addition, there is a nonlinear relationship between 
the mean of optimism and delay more than seven month. However, the statistical model 
of delay versus optimism for less than seven months and more are different. 
 
2.7  A Regression Model of Optimism and Independent Variables  
A regression model was discovered for each race with optimism as a response key and 
independent variables of age, education, and delay. For both regression models, the 
minimum residual with highest R-square is considered. 
For African Americans, the regression model is a nonlinear model, 
 ŷ= -2.68905+1.81298  3 + 0.00006589  1* 2 + 0.07823  2 + 0.34882(log(x3*x2))  
 + 0.00000555x1*x3 - 0.00002972x1*x2*x3 + ε ,   (2.19) 
  where R-Square = 0.7016, x1= (delay
2
), and x2= (education); 
 3=15.12840 + 4.84417X
½
- 12.6418X
⅓  — age is less than or equal to 57; and 
 3=2.14426 + 1.805354E26exp (  ) — age is greater than 57. 
In addition, the whites model with response variable of optimism approached    
 ŷ = ln [1.6037-3.10270(  
    + 0.000001) + 0.02087   
    
  
1/3
+ 
 0.29350(ln (  
 
 ) + exp(  
 )  - 0.121519(  
     3)],       (2.20) 
where R-Square = 0.7691 with MSE=.3125   
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 1= (delay),   2= (education) , and   
x
3
= exp(age ⅓ ) — age is less than or equal to 57;  
and x
3
=𝑎𝑔    — age is greater than 57. 
 
2.8  The Probabilistic Behavior of Tumor Size 
To understand the probabilistic behavior of the optimism, we must statistically search and 
identify the probability distribution that fits the subject data the best. We utilize three 
goodness-of-fit tests, namely, Kolmogorov-Smirnov Anderson-Darling (Anderson & 
Darling, 1952), and Chi-Square (Karl Pearson in 1900), to identify the best probability 
distribution function (pdf) for the subject data. These procedures are a general test to 
compare the fit of an observed cumulative distribution function to an expected 
cumulative distribution function. The Erlang
 
distribution function is found to be the best 
fitted probability distribution function to characterize the behavior of optimism as a 
response key variable for all patients, with the approximate maximum likelihood 
estimates of the parameter given  ̂=93,  ̂= 0.076, and   ̂= -4.55, where k is shape and β is 
scale (β > 0), and γ is continuous location parameters, and domain is [γ, ∞), with a mean 
of 2.504, a standard deviation of 0.732, skewness of 0.207, and Excess Kurtosis of 0.065. 
The actual form of the Erlang probability density function is given by         
  ̂   = 
           
 
         
      
               
  , (2.21) 
and its graph is given below, Figure 2.13: 
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Figure 2.13 The Probability Distribution Function of Actual Optimism Data  
For whites, the Burr 4-Parameter probability distribution function (pdf) is the best fit to 
characterize the optimism. The approximate maximum likelihood estimates of these 
parameters are  ̂=237.3,  ̂=4.277,   ̂=10.62 and,  ̂=0.165, where α and k are 
continuous and positive shape parameters, β is a positive continuous scale parameter, and 
γ is a continuous location parameter. Thus, the Burr 4-Parameter probability distribution 
function is given by 
  ̂   = 
            
      
     
      
            
       
     
            
  , (2.22) 
and its graph is shown below in Figure 2.14. 
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Figure 2.14 Probability Distribution Function of Actual Optimism Data for Whites  
         
The characterized behavior optimism of African-American patients is discovered 
in the Gamma distribution function with the approximate maximum likelihood estimates 
of the parameter given by parameters  ̂=11.67 and  ̂ = 0.205, where k is a shape and a 
positive integer and β is a scale and positive; the probability density function is given by  
  ̂   = 
       
  
     
                  
 , (2.23) 
The graph below shows the probability density function of optimism for African 
Americans [Figure 2.15].  
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Figure 2.15 The Probability Distribution Function of Actual Optimism Data for African Americans  
 
Thus, having identified the probability distribution for optimism for African 
Americans, we can probabilistically characterize the behavior of whites and both races 
and obtain other useful information, such as expectations of optimism, confidence limit, 
etc. 
Given in Table 2.12 below is a summary of the maximum likelihood estimator 
(MLE) of parameters of the three different probability density functions that characterize 
races.  
Table 2.9 MLE of Parameters of the Probability Density Optimism Functions for Race 
Race 
PDF MLE 90% of CI 
 
95% of CI 
 
Mean 
 
Std-Dev 
 
All 
 
Erlang- 3-
parameters 
  ̂= 93 
  ̂= -4.55 
  ̂= 0.076 
 
(1.585,  3.456 ) 
 
(1.346,  3.750 ) 
 
2.504 
 
0.732 
 
AA Burr – 4 - 
parameters 
  ̂=237. 3 
  ̂= 0.165 
  ̂= 10.62 
 ̂=4.277 
 
(1.550,  3.321) 
 
(1.550,  3.648 ) 
 
2.392 
 
0.490 
 
White 
 
 
Gamma 
 
  ̂= 11.67 
  ̂= 0.205 
 
 
(1.763,  3.613) 
 
(1.493,  3.843) 
 
2.708 
 
0.7119 
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We also represent 90% and 95% confidence limits of the true mean of optimism for each 
classification of race. For example, we are at least 90% certain that the true mean of 
optimism of all patients is between1.5847 and 3.456, or 
    (1.5847 ≤ µ ≤ 3.456) ≥ 90% , (2.24) 
 where µ is the unknown true size of the subject tumor. 
 
2.9 Conclusion 
The optimism data did not follow a normal distribution. The mean of optimism with 
respect to the races was different. Moreover, the races with respect to optimism have 
different distributions and different models. The mean of optimism had a direct 
relationship with respect to education: by increasing education, the mean of optimism is 
increasing. The mean of optimism with respect to two groups of age by intervals of four 
years is different and has different modeling. For subjects less than age 58, the rate of 
optimism increases with slow trend. For those aged 58 and older, the rate decreases. In 
addition, for each race the mean of optimism with respect to two groups of age by 
intervals of four years has different statistical models. The mean of delay with respect to 
the races was about the same. Moreover, the races with respect to delay had different 
distributions and different models. The mean of delay had an opposite relationship with 
respect to education; by increasing education, the mean of delay decreases. Moreover, it 
is shown that the mean of delay decreases by increasing the mean of optimism. Also, 
there is a nonlinear relationship between the mean of optimism and delay more than 
seven month. However, the statistical model of delay for less than seven months and 
optimism is a quadratic function. Moreover, the statistical model of optimism as function 
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of independent variables was nonlinear and changed with respect to each race. Lastly, 
using the probability distribution function is another procedure that can find more 
information about the mean of optimism. Thus, the characterized behavior optimism of 
African-American patients was followed in the Gamma distribution function with the 
approximate maximum likelihood estimates of the parameter given by parameters 
 ̂=11.67 and  ̂ = 0.205, and whites’ was discovered the Burr 4-Parameter probability 
distribution function with parameters are  ̂=237.3,  ̂=4.277,  ̂=10.62 and,  ̂=0.165.  
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Chapter 3: 
Anxiety and Breast Cancer 
 
3.1 Introduction 
Cancer is the uncontrolled growth of abnormal cells in the body, which are also called 
malignant cells. Symptoms of cancer depend on the type and location of the tumor. Cells 
are the building blocks of living things. Cancer grows out of normal cells in the body. 
Normal cells multiply when the body needs them and die when the body doesn’t need 
them. Cancer appears to occur when the growth of cells in the body is out of control and 
cells divide too quickly. It can also occur when cells “forget” how to die. 
It is important to recognize that everyone has cancer cells in their body. We have 
trillions of cells in our bodies, and there is an ongoing process in which millions of cells 
die and millions of others divide to replace them. Typically, the immune system 
devastates the cancer cells before they can divide and form new ones. Cancer tumors 
develop in weakened or disturbed parts of the body. 
What weakens the body and the immune system’s ability to obliterate the cancer 
cells? Some researchers believe that personality type C is one of the risk factors for 
cancer. Type C has emerged as a behavioral pattern, coping style, or personality type that 
predisposes people to, or is a risk factor in, the onset and progression of cancer. 
Individuals with personality type C have been described as being over-cooperative, 
stoical or self-sacrificing, appeasing, unassertive, patient, avoiding conflict, compliant 
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with external authorities, unexpressive, suppressive or in denial of negative emotions, and 
predisposed to experiencing hopelessness and depression (Bleiker, 1995; Eysenck, 1994;  
Temoshok, 1990). 
Breast cancer is the most common cancer among American women (excluding 
skin cancers). But incidences of breast cancer have been decreasing since 1999, and 
deaths due to breast cancer have been decreasing since 1990. Whether you’ve been 
diagnosed with breast cancer, are a breast cancer survivor, or are caring for someone with 
the disease, it’s important to get the facts and to keep looking forward with hope. 
The incapability to express negative feelings, mainly anger, in women with breast 
cancer has attributed to the process of defense mechanisms such as repression and denial, 
which protect the cancer-prone individual from suffering unpleasant affective conditions. 
Type C personality is defined by difficulty in expressing emotion and denial of 
negative feelings. A person with type C personality avoids conflict and exercises extreme 
control over emotional behavior as long as everything seems to be going perfectly in her 
life. Individuals with type C personality are in a stage of self-consciousness of emotional 
expression subsequent to extreme and unnecessary use of the defense mechanisms of 
repression and denial. The majority of use of the defense mechanisms of repression and 
denial is generally viewed as an unhealthy means of coping with the insufferable 
experience of negative affective states, especially anger. 
Our study consulted a PhD dissertation fro, the Department of Psychology at the 
University South Florida, “Emotions, Lifestyle Defenses and Coping in Breast Cancer 
Patients,” by Veronica Clement. The author attempted to invent whether there is a 
relationship between type C personality and breast cancer. In her study, breast cancer 
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patients were compared with healthy controls of similar age, education, and 
socioeconomic status. Type C personality characteristics of breast cancer patients were 
evaluated by examining the relationships among the measures of emotional traits, 
lifestyle defenses, and coping strategies. In her study, the author divided the personality 
inventory to six inventories based on type C personality: 
 State-Trait Personality Inventory (STPI) 
The STPI consists of six 10-item subscales for measuring state and trait anxiety, 
anger, and curiosity (Spielberger et al 1979); only the 30-item trait scale was used in the 
present study. The STPI Trait scale requires subjects to report, on a 4-point frequency 
scale, how they generally feel, using the following response options: (1) almost never, (2) 
sometimes, (3) often, and (4) almost always. This scale is shown in index 1. 
 The Anger Expression (AX) Scale 
The AX scale is a 24-item questionnaire designed to measure the mode, direction, 
and frequency of anger expression (Spielberger, 1988b). Subjects rate how they generally 
act and feel when angry; using the same 4-point frequency scale described previously for 
the STPI trait measures, shown in Index 2.  
The three AX subscales measure the extent to which anger is 
1. suppressed (AX/IN); 
2. expressed toward other people or objects in environment (AX/Out); 
3. Consciously controlled (AX/Con). 
4. Total anger expression (AX/EX) = (AX/IN) + (AX/OUT) + (AX/CON). 
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 Rationality/ Emotional Defensiveness Scale (R/ED)   
The 12-item R/ED scale (Spielberger, 1998a) provides an interaction measure of 
the process of repression and refutation as defenses against undesirable thoughts and 
feelings. Subjects respond to the R/ED scale by rating how often they use logic to deny or 
repress emotions, particularly anger, using the 4-point frequency rating scale mentioned 
in the STPI. The R/ED scale correlated positively with the AX anger-control and 
negatively with the AX anger-out, shown in Index 3. 
 Need for harmony (N/H) Scale  
In a 12-item scale (Spielberger, 1993), subjects report how often they employ 
strategies to maintain or seek harmony in relationships using the same 4-point trait 
(frequency) scale as previously described for the STPI. 
The ways of coping checklist (revised) (WCCL-R): In responding to the WCCL-
R, subjects are instructed to focus on their most serious stressor, which they list in a space 
provided. They then rate how frequently they employ each of the 57 coping responses, 
using the 4-point frequency rating scale: (1) never used, (2) rarely used, (3) sometimes 
used, and (4) regularly used, which shows in the index 4. 
The five empirically derived WCCL-R scales are 
1. Problem-focused (15 items), (active coping strategies aimed at resolving the 
problem) 
2. Avoidance (10 items), (the individual behaviorally or cognitively avoids the 
source of stress) 
3. Wishful thinking (8 items), (the degree to which the subject fantasizes or 
wishes away the source of stress) 
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4. Seek social support (6 items),  (seeks help from other) 
5. Blamed self (3 items), (blames themselves for the problem) 
6. Blamed other (6 items), ( blames others for problems as a coping strategy) 
7. Count your blessing (6 items), (focuses on positive aspects of personal 
experience)             
8. Religiosity (3 items), (faith and spirituality are employed to deal with source 
of stress)   
 Defense Mechanism Inventory (DMI) 
The DMI describes each story using four questions that inquire about the subject’s 
thoughts, affect, and behavior in the situation that is described. Five different response 
alternatives are presented for each question, representing five different defense 
mechanism clusters: 
1. Reversal (REV), (fails to acknowledge the existence of obvious danger or 
minimizes its severity) 
2. Turning the self (TAS), (used to falsify reality in order to reduce perceived 
threats to one’s self-esteem) 
3. Principalization (PRN), (the defensive use of truisms and clichés to reinterpret 
reality) 
4. Turning against the subject (TAO), (subject expresses direct or indirect 
aggression in order to master perceived external threats or mask inner 
conflicts) 
5. Projection (PRO), (the justification of one’s hostile thoughts and feelings by 
attributing negative or harmful intent to others) 
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These tests were rated with most and least likely responses, using a 4-point frequency 
likert scale. 
 Brief symptom inventory (BSI): 
The BSI was used to assess subjects’ current level of psychological distress. The 
test included 53 items that assess the experiences of verity of somatic or psychological 
symptoms. Subjects rate the degree to which they have been bothered by the symptoms 
listed during the past week, including that day, using a 5-point intensity scale ranging 
from 0-not at all, to 4-extremely bothersome. 
The BSI has nine dimensions of psychological adjustment: 
1. Somatization 
2. Depression 
3. Obsessive-compulsiveness 
4. Interpersonal sensitivity 
5. Depression anxiety 
6.  Hostility 
7. Phobic anxiety  
8. Psychoticism 
9. Paranoid ideation 
The following hypotheses of her study based on the research literature and 
Clément’s study in 1991 were formulated to predicted differences in emotional traits, 
lifestyle defenses, and coping strategies between cancer patients and healthy controls:  
In state of Emotional Traits: 
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1. Whether the breast cancer patients will experience anxiety and anger less 
frequently than healthy controls, as evidenced by lower scores on the STPI Trait Anxiety 
(T-Anxiety) and Trait Anger (T-Anger) subscales. 
2. Whether the breast cancer patients will express less anger outwardly, and 
show less total anger expression, as compared to healthy controls. Therefore, breast 
cancer patients were expected to have lower scores on the STAXI AX/Out and AX/Ex 
subscales. 
3. Whether breast cancer patients display greater suppression and controls of 
anger as compared to healthy controls. However, breast cancer patients were expected to 
have higher scores on the STAXI AX/In and AX/Con subscales. 
In state of Lifestyles Defenses: 
4. Whether the breast cancer patients have greater general use of suppressive 
defense mechanism than healthy controls. However, breast cancer patients were expected 
to score higher on the DMI REV (reversal) and principalization (PRIN) subscales, which 
assess repressive defensive processes and unconscious use of renationalization and 
intellectualization to avoid negative emotions. 
5. Whether breast cancer patients display less hostility than healthy controls, and 
are less likely to attribute negative intent to others. Thus, the breast cancer patients were 
predicted to have lower scores on the DMI Turn against Object (TAO) and Projection 
(PRO) subscales, which measure direct and indirect hostility.   
6. Whether the breast cancer patients focus on positive aspects of personal 
experience, use rational problem-solving strategies, and seek social support more often 
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than healthy controls. Thus, the cancer patients were expected to score higher on the 
WCCL Count Your Blessing, Problem-Focused Coping, and Seek Social Support 
subscales. 
7. Whether breast Cancer patients blame others for their problems less than 
healthy controls to avoid conflict. Consequently, breast cancer patients were predicted to 
have lower scores on the WCCL, Blamed Others subscale.   
In our study, we imply a statistical reviewing of Clement responding to whether 
there is any relationship with type C personality and breast cancer.   
1. Does age affect the relationship between cancer and State-Trait Personality? 
2. Is there a difference between the mean of cancer and healthy groups with 
respect to State-Trait Personality? 
 
3.2  Method and Computation 
3.2.1  Method 
For her intention, the author performed some statistical tests such as T-test and 
multivariate analysis tests by assumption of the normality on a sample size of 82 women 
between ages 30 and 60, 47 of whom were cancer patients (cancer group) and 35 of 
whom were healthy (control group).  
 
3.2.2  Computation 
In this study, we attempted to look over Clement’s results from a statistical perspective. It 
is not clear if the author did the normality test for the data or the data had a probability 
normal distribution (pdf). 
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Thus, in the present study, we attempted to redo her results using a different t-test, 
such as two-tails t-test, with and without equal variances, one-tail t-test and paired t-test, 
and nonparametric test over all, since the t-test and anova tests were used for her study 
and the results shown in the Table 3.1 below.  Our computation tests follow. 
 Unequal sample sizes, unequal v or variance or Welch’s t-test: 
The t- test is used when the two population variances are assumed to be different 
(the two sample sizes may or may not be equal) and hence must be estimated separately. 
The t statistic to test whether the population means are different can be calculated as 
follows: 
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The test for the significance of the differences between two means for dependent samples 
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where    s
2
POOLED = 
                  
        
. (3.3)  
 Paired t-test computation:  
A statistical paired t-test is a type of location test that is used when two samples 
are measured to determine whether their population means are different from each other. 
The paired sample t-test is used in “before-after” studies, or when the samples are 
the matched pairs, or when the case is a control study. Most instances of a paired 
different t-test occur when subjects are measured before and after a treatment. Generally, 
a paired t-test has more power than an unpaired test, as these measurements are compared 
within subjects, rather than across subjects. 
 Assumptions: 
1. Only the matched pair can be used to perform the test. 
2. Normal distributions are assumed. 
3. The variance of two samples is equal. 
4. Cases must be independent of each other.  
The following formula is used to calculate the parameter t for the paired sample t-test: 
    
 ̅
√ 
 
 
 ,             (3.4) 
where  ̅  is the mean difference between two sample means, s² is the sample variance for 
group difference, n is the sample size, and t is a paired sample t-test with n-1 degrees of 
freedom. 
Finally, an alternate formula for the paired sample t-test is performed based on 
     
∑ 
√  ∑ 
    ∑   
   
 .   (3.5) 
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However, in our study the pair test is not performed because the data was not provided to 
us. 
Test Hypothesis: 
Hypothesis tests are decisions that required to be made concerning populations on 
the basis of sample information. The decisions are made base on the statistical tests. 
There are five requirements steps for any statistical test: 
1. Null Hypothesis  
2. Alternate Hypothesis 
3. Test Statistic  
4. Rejection/Critical Region  
5. Conclusion 
In attempting to reach a decision, it is useful to make an assumption about the 
population involved, such as the type of distribution. 
Statistical Hypotheses: These are defined as assertions about the parameter or 
parameters of a population; for example, the mean or the variance of a normal population. 
They may also concern the type, nature, or probability distribution of the population. 
Statistical hypotheses are based on the concept of proof by contradiction. For example, 
say we test the mean of a population (µ) to see if an experiment has caused an increase or 
decrease in µ. We do this by proof of contradiction by formulating a null hypothesis. 
Null Hypothesis: This is a hypothesis that states that there is no difference 
between the procedures, and it is denoted by H0. For the above example, the 
corresponding H0 would be that there has been no increase or decrease in the mean. 
Always the null hypothesis is tested, i.e., we want to either accept or reject the null 
hypothesis because we have information only for the null hypothesis. 
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Alternative Hypothesis: This is a hypothesis that states that there is a difference 
between the procedures, and it is denoted by Ha. 
Our test hypothesis is based on: 
 Two-tailed test: 
 H0:μ1 =μ2   vs.     Ha: μ1 ≠μ2  (3.6) 
 One-tailed test: 
 H0:μ1 =μ2   vs.    Ha: μ1 >μ2     or   Ha: μ1 <μ2  (3.7) 
 Two-tailed test critical rejection: 
 |t0| > t    
 
 
       or   |t0| < t   
 
 
      ,   (3.8) 
where the samples tests are dependent on degree of freedom df =n1+n2 -2.  
In cases when samples tests are dependent, the degree of freedom is 
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which is also called the Welch-Satterthwaite equation.  
Our rejection region was based on: 
 Two-tailed test critical rejection: 
 
  t0 > t   
 
 
      or    t0 < t   
 
 
      (3.10) 
                  
 One-tailed test critical rejection: 
 
  t0 > t (α,  )    or    t0 < -t (α,  ) (3.11)   
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Nonparametric Test: 
Parametric tests are preferred because, in general, for the same number of 
observations, they are more likely to lead to the rejection of a false hull hypothesis. That 
is, they have more power. This greater power stems from the fact that if the data have 
been collected at an interval or ratio level, information is lost in the conversion to ranked 
data (i.e., merely ordering the data from the lowest to the highest value). Occasionally, 
the assumptions of the t-tests are seriously violated—in particular, if the type of data is 
ordinal in nature and not at least interval. On such occasions an alternative approach is to 
use nonparametric tests. Nonparametric tests are also referred to as distribution-free tests. 
These tests have the obvious advantage of not requiring the assumption of normality or 
the assumption of homogeneity of variance. They compare medians rather than means 
and, as a result, if the data have one or two outliers, their influence is negated. Generally, 
all commonly used nonparametric tests rank the outcome variable from low to high and 
then analyze the ranks. These tests are listed in the second column of the table and 
include the Wilcoxon, Mann-Whitney test, and Kruskal-Wallis tests. These tests are also 
called distribution-free tests. 
 
The Kruskal-Wallis Test: 
H-test goes by various names, including Kruskal-Wallis one-way analysis of 
variance by ranks (e.g., in Siegel & Castellan, 1988). It is for use with k independent 
groups, where k is equal to or greater than 3, and measurement is at least ordinal. (When 
k = 2, you would use the Mann-Whitney U-test instead.) Note that because the samples 
are independent, they can be of different sizes.  
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The null hypothesis is that the k samples come from the same population, or from 
populations with identical medians.  
The alternative hypothesis states that not all population medians are equal.  
It is assumed that the underlying distributions are continuous; but only ordinal 
measurement is required. 
The statistic H (sometimes also called KW) can be calculated in one of two ways: 
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   ̅   ̅•),             (3.12) 
where k = the number of independent samples ni = the number of cases in the i
th
 sample,  
N = the total number of cases, Ri = the sum of the ranks in the i
th
 sample,   ̅ = the mean of 
the ranks for the i
th 
sample, and  ̅• = 
   
 
 = the mean of all ranks. 
 
Mann-Whitney U Test (for 2 independent samples): 
The most basic independent groups design has two groups. These are often called 
Experimental and Control. Subjects are randomly selected from the population and 
randomly assigned to two groups. There is no basis for pairing scores. Nor is it necessary 
to have the same number of scores in the two groups. 
The Mann-Whitney U test is a nonparametric test that can be used to analyze data 
from a two-group independent groups design when measurement is at least ordinal. It 
analyzes the degree of separation (or the amount of overlap) between the Experimental 
and Control groups. 
The null hypothesis assumes that the two sets of scores are samples from the same 
population; therefore, because sampling was random, the two sets of scores do not differ 
systematically from each other. 
52 
The alternative hypothesis, on the other hand, states that the two sets of scores do 
differ systematically. If the alternative is directional, or one-tailed, it further specifies the 
direction of the difference. 
The statistic that is calculated is either U or U'. 
U1 = the number of first group less than second group 
U2 = the number of second group less than first 
U = the smaller of the two values calculated above 
U' = the larger of the two values calculated above, 
 where µR 
           
 
  ,      (3.13) 
 σR = √
             
  
 ,  (3.14) 
and statistics   zt = 
     
  
. 
When the total number of scores is small, U can be calculated directly by counting the 
number of first group less than second. 
Calculating U with Formula: 
 When the total number of scores is a bit larger, or if there are tied scores, it may 
be more convenient to calculate U with the following formulae: 
          
        
 
       (3.15) 
          
        
 
    ,           (3.16)                                    
where n1 = # of scores in group 1, n2 = # of scores in group 2, R1 = sum of ranks for group 
1, and R2 = sum of ranks for group 2. As before, U = the smaller value of U1 and U2, and 
U' = the larger value of U1 and U2. 
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3.3  State-Trait Personality Inventory (STPI) 
Anxiety, anger, depression, and curiosity are major indicators of psychological disorder 
behavior. State-Trait Personality Inventory (STPI) is a measure of anxiety, anger, 
depression, and curiosity. By trait instruction the author asked patients to report how they 
generally felt by scoring the frequency that anxiety-related feelings, cognitions, and 
symptoms described by each item were experienced.  
 
3.3.1  State-Trait Personality Inventory (STPI) for Younger Ages 
The table below shows comparable results of our t-test (two-sided and one-sided) 
performance and Clément’s, based on the test hypothesis of whether the mean of anxiety 
between cancer and control groups are the same for ages 50 and lower. 
Table 3.1 Anxiety T-test and Paired T-test for Ages 50 and Less 
State Trait      Cancer      Healthy        t pooled       t satterthwaith    one tail α=.05    t value       Decision             
                        n=20            n=27                                                              t-test                     V. Clement 
Anxiety                                                         
Mean             18.65          19.19               -1.670             -1.636                  √                           0.35              √ 
SD                   1.18            1.03                                                                   
 
Anger                                                        
Mean             14.40          17.74               -1.312              -1.288                 √                           0.27              √ 
SD                   0.94            0.83                                                                   
 
Curiosity                                                       
Mean             28.20          27.56               1.988                1.950                *Reject                   0.41              √ 
SD                   1.17            1.03                                                                   
 
T-Anger/Temp.                                                        
Mean             6.55            6.26                2.469                2.424                  Reject                    0.48              √ 
SD                   0.44            0.39                                                                   
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T-Anger/Reaction                                                        
Mean             8.00           8.44                 -2.618               -2.556                  Reject                0.55             √ 
SD                  0 .62           0 .53                                                                   
 
Anger Express.                                                      
Mean             20.95          21.14              -0.317            -0.311                       √                     0.07                   √ 
SD                   2.18           1.92                                                                  
 
Anger /Out                                                       
Mean             13.95        13.89              0.260               0.254                        √                        0.76              √ 
SD                   0.85           0.73                                                                   
 
Anger /control                                                      
Mean             24.25         23.11               3.670               3.590                     Reject                    0.70            √ 
SD                   1.20          1.07                                                                   
 
Anger /In                                                      
Mean             15.25        14.37                  3.430              3.370                  Reject                    0.76              √ 
SD                   0.88           0.76                                                                   
* In these cases H0 test failed to reject by two-tailed pooled t-test and satterthwait t-test 
 
Results: 
 As can be seen in Table 3.1, in all cases, the results of our statistics test for state 
trait of anxiety for ages 50 and less indicate similarity with Clément’s decision (failed to 
reject the test hypothesis). However, in the cases of T-anger/Temp, T-Anger/reaction, 
Anger/Control, and Anger/In, our statistics tests do not follow hers. Moreover, in the trait 
emotion for curiosity, the results of two-tailed pooled t-test and satterthwait t-test failed 
to reject.  
 
3.3.2  State-Trait Personality Inventory (STPI) for Older Ages 
The results of two-tailed and one-tailed t-test with dependent and independent degree of 
freedom based on the test hypothesis of whether the mean of anxiety between cancer and 
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control groups are the same for ages greater than 50 and are shown in the Table 3.2. 
Table 3.2 displays comparable results of our performances and hers.  
Table 3.2 State-Trait Personality Inventory (STPI) Age 51 and Greater 
 
Sate Trait      Cancer      Healthy        t pooled       t satterthwaith    one tail α=.05    t value       Decision             
                        n=27            n=8                                                              t-test=1.686         V. Clement 
Anxiety                                                         
Mean             16.96          15.38               3.104             2.348                 Reject                  0.75                √ 
SD                   1.01            1.86                                                                  
 
Anger                                                        
Mean             15.54         15.88               -0.805              -0.607                 √                           0.19              √ 
SD                   0.82            1.52                                                                  
 
Curiosity                                                       
Mean             28.89          31.37               -4.744                -3.564                Reject               1.16              √ 
SD                   1.01            1.89                                                                   
 
T-Anger/Temp.                                                        
Mean             4.92            5.25               -1.688                -1.246                  √                        0.39              √ 
SD                   0.38            0.72                                                                   
 
T-Anger/Reaction                                                        
Mean             7.92           8.25                 -1.204               -0.921                  √                      0.29               √ 
SD                  0 .54           0 .97                                                                  
 
Anger Express.                                                      
Mean             15.85          18.25              -2.463            -1.847                **Reject           0.60                  √ 
SD                   1.88            3.53                                                                 
 
Anger /Out                                                       
Mean             12.33        14.25              -5.111               -3.859                Reject              1.24                √ 
SD                   0.85           0.73                                                                   
 
Anger /In                                                      
Mean             14.04         13.00             2.673               2.028                  **Reject          0.65                √ 
SD                   0.76          1.39                                                                  
 
Anger /Control.                                                       
Mean            26.52         25.00             2.814                2.107                    Reject               0.68             √ 
SD                   1.04           1.96                                                                  
** In these cases H0 test rejected by pooled t-test and fail to reject with satterthwait t-test 
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Results: 
 In all trait sections, our results of State trait of anxiety for ages more than 50 do 
not indicate the same Clément’s decision (fail to reject the test hypothesis in all cases). 
However, in the cases of Anger, T-anger/Temp and T-Anger/reaction our statistics tests 
maintain as hers. Moreover, in the trait emotion for curiosity, the results of two tail 
pooled t-test and satterthwait t-test of are failed to rejected. Moreover, in State trait of 
anxiety in cases of Anger/In and Anger/express, our statistical t-tests reject the hypothesis 
test except the satterthwait t-test fail to reject. 
 
3.4  Rationality/Emotional Defensive Scale (R/ED)  
The R/ED scale is a measure of psychological defenses in the test-subject population who 
occupy states of repression and denial as defenses against unacceptable angry thoughts 
and feelings. For measuring the R/ED, it was scored the frequency of rating symptoms of 
each item for those patients were asked how they rationally denied or repressed their 
emotion, particularly their anger; for instance, “I try to do what is sensible or logical …” 
In the next section, Tables 3.3 and 3.4 show comparison results of test hypothesis 
of whether the mean of R/ED between the cancer and control groups are the same for 
ages 50 and less and for ages greater than 50.  
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Table 3.3 Mean and Deviation and Comparison of T-test of Scores on the (R/ED), N/H, and DMI Defense 
Mechanism Scale for Breast Cancer Patients and Healthy patients for Ages 50 and Less 
Defense      Cancer     Healthy     t pooled       t satterthwaith    one tail α=.05              t value       Decision             
                        n=20            n=27                                                              t-test                                          V. 
Clement 
R/ED                                                        
Mean             37.25          36.41               2.401            2.347                  Reject               0.53             √    
SD                   1.21            1.04                                                                   
EMD                                                        
Mean             13.80          14.00               -0.981              -0.970                 √                    0.20              √ 
SD                   0.74            0.64                                                                   
RAT                                                       
Mean             17.50          16.70               6.150                6.005                Reject             1.27             √ 
SD                   0.48            0.41                                                                   
N/H                                                        
Mean            35.60           39.37             -9.383                -9.149                Reject           1.94*       Reject 
SD                   1.49            1.26                                                                   
HAR                                                       
Mean             15.95         17.11                 -6.676            -6.492                  Reject           1.39              √ 
SD                  0 .65           0 .54                                                                   
SS                                                     
Mean             13.20        15.22              -9.028               -8.834                Reject              1.88
*
              √ 
SD                   0.82           0.71                                                                  
Projection                                                      
Mean             9.84          11.00                 -6.676            -6.492                  Reject            1.38                √  
SD                   0.65           0.54                                                               
Turn Against self 
Mean              6.21         5.63                       4.837               4.731               Reject          0.98                  √ 
SD                   0.44         0.38 
Principalization 
Mean              9.26         9.11                       1.167                  1.135               √                   0.98               √ 
SD                   0 .48         0.40 
Turn Against                                                      
Mean             7.89         8.33                      -2.868             -2.795                     Reject        0.98                √ 
SD                  0 .57          0.48                                                                
Reversal                                                     
Mean             8.89           8.85                    0.230              0.224                        √                 0.76              √ 
SD                   0.65           0.54                                                                   
√* is used for the cases two sides and one side of t-tests were the result of pooled t-tests rejected the H0 but 
the satterthwaite t-tests was fail to reject. 
  
 
Results:  
As has been shown in Table 3.4, our results of R/ED, N/H, and DMI defense 
mechanism scales for ages less than 50 do not indicate the same decision as Clément’s. 
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Her decision failed to reject the test hypothesis in all cases except on N/H. In most 
circumstances, our outcomes of statistical t-test rejected the null hypothesis of quality 
mean between cancer and control groups. However, in the cases of EMD, 
Principalization, and Reversal, we failed to reject the test hypothesis. 
Table 3.4 Mean and Deviation and Comparison of T-test of Scores on the (R/ED), N/H, and DMI  
Defense Mechanism Scale for Breast Cancer Patients and Healthy Patients for Ages Greater than 50 
Defense      Cancer     Healthy     t pooled       t satterthwaith   One tail      Two tail           t value     Decision             
                        n=27            n=8                                                 t-test  α=.05   t-testα=.05     V. Clement 
R/ED                                                        
Mean             38.30          38.12               0.351           0.256                  √                                      0.08             √    
SD                   1.04            1.91                                                                   
EMD                                                        
Mean             14.04          14.06               -1.840              -1.344            Reject                               0.44             √ 
SD                   0.64            1.17                                                                  
RAT                                                       
Mean             17.92         17.75               0.842                0.614                    √                                  1.21             √ 
SD                   0.41            0.75                                                                   
N/H                                                        
Mean            38.96           36.50                3.190                2.861              Reject                            0.93          Reject 
SD                   1.49            1.26                                                                   
HAR                                                       
Mean             16.74          16.00                 2.779            2.027                  Reject                            0.66              √ 
SD                  0 .65           0 .54                                                                   
SS                                                     
Mean             15.18        13.62                4.479             3.277                    Reject                               1.06            √ 
SD                   0.71           1.29                                                                  
Projection                                                      
Mean             10.88          9.75                 4.802            3.076                      Reject                            0.98             √  
SD                   0.54           0.99                                                               
Turn Against self 
Mean              5.79         5.12                       3.471               2.585               Reject                            0.82              √ 
SD                   0.40         0.70 
Principalization 
Mean              8.75         8.50                       1.214                0.911                      √                            0.29                √ 
SD                   0 .43         0.74 
Turn Against                                                      
Mean             7.92           7.00                      3.761             2.82                      Reject                        0.90                √ 
SD                  0 .51          0.88                                                                
Reversal                                                     
Mean             7.87            9.12                       -4.453              -3.362             Reject                       1.08                 √ 
SD                   0.59           1.00                                                                  
√* is used when the cases two-sided and one-sided of t-tests were the result of pooled t-tests rejecting the 
H0 but the satterthwaite t-tests failed to reject. 
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Results:  
As can be see, in Table 3.4, our results of R/ED, N/H, and DMI defense 
mechanism scales for ages greater than 50 do not indicate the same decision as 
Clément’s. Her decision failed to reject the test hypothesis in all cases except in N/H. In 
most circumstances, our outcomes of statistical t-test rejected the null hypothesis of 
quality mean between cancer and control groups. However, in the cases of R/ ED, 
Principalization, N/H, and RAT, our statistics tests result according to hers. 
 
3.5   Way of Coping (WCC) 
In responding to the WCC, subjects are instructed to focus on their serious stressor, 
which they list in a space provided. The WCC evaluation contains questions that address 
five scaled areas: Problem-focus (15 items), Avoidance (10 items), Wishful Thinking (8 
items), Seeks Social Support (6 items), and Blames Self (3 items). 
The frequency scales are measured by rating each question (42 questions) based 
on a four-point scale: 1- Never used, 2- Rarely used, 4- Sometimes used, and 4- 
Regularly used. 
The Problem-focused subscale measures the extent to a subject that resolves 
problems. The Avoidance subscale measures the extent to which the individual 
psychologically avoids the source of stress. The Wishful Thinking subscale assesses the 
degree to which the subject imagines or wishes away the source of stress. The other two 
scales measure that the levels at which subjects seek help from others or blame 
themselves for the problem. 
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Tables 3.5 and 3.6 show the comparison results of our statistics performance tests 
and the Clément’s results for WCC between the cancer and control groups with respect to 
age. 
 
Table 3.5 Mean and Deviation and Comparison of T-test with α=.05 for Scores on the Coping Scale for 
Breast Cancer Patients and Healthy Patients for Ages Less than 50 
Coping      Cancer     Healthy     t pooled       t satterthwaith      one tail       Two tail      t value      Decision             
                    n=20           n=27                                                          t-test            t-test         Clement       Clement 
 
Problem Focused 
Mean             31.21          30.19        2.350         2.291                   Reject        Reject              0.48            √    
SD                   1.61            1.36       
                                                             
Seeks Social Support                                                        
Mean             11.53          11.55               -0.085             -0.0823        √              √                   0.03               √ 
SD                   0.88            0.74     
                                                              
Blamed Self                                                       
Mean             3.67             4.00               -2.037                -1.977      Reject          √*                  0.42             √ 
SD                   0.61            0.50   
                                                                 
Wishful Thinking                                                        
Mean            14.68            15.73             -4.061            -3.958        Reject         Reject              0.84            √ 
SD                   0.96              0.81    
                                                                
Avoidance                                                      
Mean             12.94         12.92                 0.073            0.071              √              √                  0.02                √ 
SD                  1.01           0.87      
                                                              
Blamed Others                                                     
Mean             4.94            6.74              -7.047               -6.843                Reject      Reject            1.46          √ 
SD                   0.96           0.79     
                                                              
Count Your Blessings                                                      
Mean             14.79           13.96               5.768            5.617              Reject         Reject             0.98           √  
SD                   0.65           0.55     
                                                           
Religiosity 
Mean              5.58        4.63                       8.589               8.380               Reject       Reject         1.62            √ 
SD                   0.53         0.45 
√* is used for the cases two sides and one side of t-tests were the result of pooled t-tests rejected the H0 5.7 
the satterthwaite t-tests failed to reject. 
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Table 3.6 Mean and Deviation and Comparison of T-test with α=.05 for Scores on the Coping Scale for 
Breast Cancer Patients and Healthy patients for Ages Greater than 50 
Coping      Cancer     Healthy     t pooled       t satterthwaith   one tail       Two tail            t value      Decision             
                    n=27            n=8                                                      t-test              t-test              Clement    Clement 
Problem Focused 
Mean             29.75         32.28               -3.582            -2.609         Reject      Reject              0.85               √    
SD                   1.43            2.63                                     
Seeks Social Support                                                        
Mean             11.50          11.86               -0.945              -0.672            √             √                   0.22               √ 
SD                   0.75            1.46                                    
Blamed Self                                                       
Mean             3.32             3.28               0.155                0.111                 √           √                    0.03             √ 
SD                   0.51            0.98                 
Wishful Thinking                                                        
Mean            13.50            14.43             -2.238                -1.593               √          √*                 0.52              √ 
SD                   0.82              1.59                                           
Avoidance                                                      
Mean             11.04        11.14                 -0.227            -0.161                 √            √                   0.05             √ 
SD                  0.87           1.69                              
Blamed Others                                                     
Mean             3.62            7.14              -8.769               -6.298                Reject      Reject          2.05           √ 
SD                   0.80           1.52                 
Count Your Blessings                                                      
Mean             14.08           13.43                2.318            1.667                  Reject         √*            0.54            √  
SD                   0.56           1.06                                
Religiosity 
Mean              5.11        3.43                       7.254               5.194               Reject       Reject        1.69          √ 
SD                   0.46         0.88 
√* is used for the cases two sides and one side of t-tests were the result of pooled t-tests rejected the H0 but 
the satterthwaite t-tests failed to reject. 
 
Summary: 
As can be seen in Table 3.6, in all cases our results of different t-tests do not 
prove Clément’s results. However, in the cases of Seek Social Support and Avoidance, 
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we failed to reject the null hypothesis of equality mean of the coping scales between 
cancer subjects and healthy subjects of younger ages as Clément’s did. Moreover, in the 
case of Blamed Self, the outcome of Scatterwaite t-test failed to reject for both two-tailed 
and one-tailed t-tests but the pool t-test did reject.    
For older subjects, Table 3.6 shows that our outcomes in circumstances of 
Problem Focused, Blamed Others, and Religiosity in both two-tailed and one-tailed t-
tests rejected the test hypothesis of the mean equality of the coping scales, which does not 
agree with Clément’s results. 
Also, in the sections of Wishful Thinking and Count Your Blessings, our 
Outcomes of the pooled-t-test rejected the null hypothesis in both one-tailed and two-
tailed t-test. Moreover, in the cases of Seeks Social Support, Blamed Self, and 
Avoidance, our performances found the same results as Clément’s. 
 
3.6  State of Trait between Cancer and Control Groups  
In this section, the results of two-tailed and one-tailed t-test with dependent and 
independent under the null hypothesis test whether the mean of anxiety between cancer 
and control groups are the same are displayed in Table 3.7. The table shows our decisions 
and Clément’s based on parametric statistic test (t-pooled and t – satterwaith) 
performances between breast cancer patients and healthy groups.  
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Table 3.7 Mean and Deviation and Comparison of T-test with α=.05 for Scores on State of Trait of Anxiety 
for Breast Cancer Patients and Healthy Patients for Ages Greater than 50 
                         Cancer( n=47)                      Healthy(n=35)        t pooled         t satterthwaith       Decision  Clément’s   
                       Mean         Std                        Mean       Std 
Anxiety                                                         
                       17.805         0 .845          17.285    1.905         2.149              1.833                     R           √ 
Anger                                                        
                        16.470        0.930              16.810    0.93        -1.519            -1.438                     √            √                                                         
Curiosity                                                       
                          28.545      0.345            29.465     1.905        3.690                -3.134                    R           √ 
T-Anger/Temp.                                                        
                             5.735     0.815           5.750     0.500           -0.098                -0.134                    R           √ 
T-Anger/Reaction                                                        
                              7.960      0.040             8.345   0.095          -2.135               -2.521                     R           √ 
Anger Express.                                                      
                            18.400        2.550         19.695   1.445          -3.804               -2.365                     R          √ 
Anger /Out                                                      
                            13.140   0.810        14.645     0.180               -4.400               -4.424                   R           √ 
Anger /control                                                      
                             25.385     1.135         24.055  0.945              5.249                4.439                     √          √ 
Anger /In                                                      
                            14.645       0.605          13.685     06.80           4.463              4.413                    R           √ 
Problem Focused 
                           30.480     1.52         31.235          1.995            -2.577             -1.871                     R            √                                                     
R/ED                                                        
                              37.75       0.778          37.265     1.209           1.925            1.625                     R           √ 
EMD                                                        
                             13.92       0.170          14.31        0.438           -1.976            -2.130                   √            √ 
RAT                                                       
                            17.71       0.297          17.225       0.742           3.065             4.125                     R           √ 
N/H                                                        
                            37.28        2.029         37.935      2.029             -2.346           -1.790                    R            √  
HAR                                                       
                           16.345    0.559          16.555        0.785           -1.151           -1.348                     R            √ 
SS                                                     
                            14.19       1.400         14.42         1.131             -1.108          -1.136                     R            √ 
Projection                                                      
                            10.36      0.735          10.375       0.884             -0.081           -0.094                    R            √  
Turn Against self 
                            6.000     0.267           5.375         0.361               4.061            5.614                    R            √ 
Principalization 
                             9.005     0.361          8.805         0.431               1.254            1.679                     √            √ 
Turn Against                                                      
                            7.905     0.0212        7.665         0.940              1.381               1.670                    R           √ 
Reversal                                                     
                            8.38       0.721         8.985            0.191               -3.252           -3.735                   √            √ 
Seeks Social Support                                                        
                            11.515    0.815     11.705            0.11               -0.880             -0.861                     √            √                                                      
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Blamed Self                                                       
                                3.495      0.56         3.64        0.740                 -0.971             -0.814                  √            √ 
Wishful Thinking                                                        
                                 14.09      0.890           15.08   1.200              -4.387              -4.111                 R           √                                                  
Avoidance                                                      
                                11.99        0.940         12.03      1.280           -0.172              -0.156                  √            √                                                           
Blamed Others                                                     
                                4.34          0.880         6.960       1.155           -11.933          -11.985                 R    rejected                                                            
Count Your Blessings                                                      
                                14.525   0.605         13.695    0.805                 4.475             5.118                  R           √                                                      
Religiosity 
                                  5.345       0.495        3.89      0.665                8.653              10.891               R   rejected 
             
 
Summary: 
 
As can be seen in Table 3.7, the results under the hypothesis test of whether the 
mean cancer and control groups were the same in each state of traits indicates the 
following: 
 Breast cancer patients would experience more anxiety, Anger/In and anger 
control, less curiosity, temper, and anger-reaction than the healthy groups. 
 There is significant difference in the mean of breast cancer patients from the 
controls on the measure of anger control, which is the same result as 
Clément’s.  However, in the case of State of Anxiety, we did not find the same 
results as her; we rejected the null hypothesis tests. In these cases, the means 
of cancer patients and control groups are significantly different. 
 In coping states, cancer patients exhibited fewer instances of Problem-
focused, Wishful Thinking, Seek Social Support, Blamed Self, Avoidance, 
and Blamed Others, and more instances of Count Your Blessings and 
Religiosity than the healthy group.  
 However, there are not significant differences between the mean of cancer and 
control groups in cases of Seeks Social Support, Blamed Self, and Avoidance, 
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which is the same result as Clément’s. In other circumstances of state of 
coping, the means of breast cancer patients and the healthy group are 
significantly different. Moreover, in Blamed Others and Religiosity, our 
results are the same as Clément’s.   
 In defense states, the means of breast cancer patients are more in EMD, N/H, 
Turn Against, Principalization, and Turn Against Self than the control group. 
 In the state of defense trait, our results rejected the test equality mean of test 
hypothesis between the cancer and healthy groups. However, the results of 
statistical tests over the mean of EMD, Principalization, and Reversal are not 
significantly different between the two groups and our decisions agree with 
Clément’s. Moreover, in other cases of defense traits, our decisions do not 
support Clément’s and reject the null hypothesis. 
 
3.7  Conclusion 
Statistical analyses may be invalid if the assumptions behind those tests are violated.  
 Prior to conducting analyses, the distribution of the data should be examined for 
departures from normality, such as skewness or outliers. If the data are normally 
distributed, and other assumptions are met, parametric tests are the most powerful. If the 
data are non-normal but other criteria are met, nonparametric statistics provide valid 
analyses. When neither set of assumptions has been met, both tests should be 
implemented to see if they agree. 
Since the raw data were not accessible to us, we could not achieve any 
nonparametric statistical tests and we are not sure whether the data were normally 
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distributed or it was just assumed by Clément. However, our results responded to the 
questions, which are based on our parametric statistic tests: 
In State of Emotional Traits: 
1. Whether the breast cancer patients will experience anxiety and anger less 
frequently than healthy controls, as evidenced by lower scores on the STPI Trait Anxiety 
(T-Anxiety) and Trait Anger (T-Anger) subscales. 
 For anxiety, T-anger -In/Out, our results show that the mean of breast cancer 
patients and the healthy group contain significant differences; however, Clément’s results 
show that the mean of these two groups is the same. However, in State Anger trait, the 
mean of breast cancer patients and the control group are the same.   
2. Whether the breast cancer patients will express less anger outwardly, and 
show less total anger expression, as compared to healthy controls. Breast cancer patients 
are expected to have lower scores on the STAXI AX/Out and AX/Ex subscales. 
The means of the cancer group and the healthy group are significantly different in 
the cases of Anger- In/Out, and Anger Express. However, our results and Clement’s show 
there is no difference between the mean of anger control for these two groups. 
3. Whether breast cancer patients display greater suppression and control of 
anger as compared to healthy controls.  
As can be seen in Table 6.1, the parametric t-test shows there is no significant 
difference between the mean of the two groups. The cancer patients have the same 
control over their anger as the healthy group.  
Moreover, for the State-trait of anxiety for ages 50 and less, our statistical 
outcomes show similarity with Clément’s decision (failed to reject the test hypothesis). 
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However, in the cases of T-anger/Temp, T-Anger/reaction, Anger/Control, and Anger/In, 
our statistics tests do not follow hers. For ages greater than 50 in the State-trait of anxiety, 
our outcomes do not indicate the same as Clément’s decision (failed to reject the test 
hypothesis in all cases). However, in the cases of Anger, T-anger/Temp, and T-
Anger/reaction, our statistics tests maintain as hers. Moreover, in the trait emotion for 
Curiosity, the results of the two-tailed pooled t-test and the satterthwait-t-test failed to 
reject. Moreover, in State-trait of anxiety in cases of Anger/In and Anger/express, our 
statistical t-tests rejected the hypothesis test, except the satterthwait-t-test failed to reject.  
In State of Lifestyles Defenses: 
4. Whether the breast cancer patients have greater general use of suppressive 
defense mechanisms than the healthy controls. Breast cancer patients were expected to 
score higher on the DMI REV (reversal) and Principalization (PRIN) subscales, which 
assess repressive defensive processes and unconscious use of renationalization and 
intellectualization to avoid negative emotions. 
The results of our statistical test show the means of the breast cancer and the 
control groups have the same scores for EMD, Principalization, and Reversal. 
5. Whether breast cancer patients display less hostility than healthy controls, and 
are less likely to attribute negative intent to others.  
As can be seen, the outcomes of table show the means of the two groups are 
significantly different for R/ED, RAT, N/H, SS, Projection, Turn-Against-Self, and Turn-
Against, which do not support the Clément’s decisions. 
Moreover, as shown in Table 4.1, our results of R/ED, N/H, and DMI defense 
mechanism scales for ages less than 50 do not indicate the same as Clément’s decision. 
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Her decision failed to reject the test hypothesis in all cases except on N/H. In most 
circumstances, our outcomes of statistical t-test rejected the null hypothesis of quality 
mean between the cancer and control groups. However, in the cases of EMD, 
Principalization, and Reversal, we failed to reject the test null hypothesis. Also, as seen in 
Table 4.2, our results of R/ED, N/H, and DMI defense mechanism scales for ages greater 
than 50 do not indicate the same as Clément’s decision. Her decision failed to reject the 
test hypothesis in all cases except on N/H. In most circumstances, our outcomes of 
statistical t-tests rejected the null hypothesis of quality mean between the cancer and 
control groups. However, in the cases of R/ ED, Principalization, N/H, and RAT, our 
statistics tests maintain as hers. 
In State of Coping: 
6. Whether the breast cancer patients focus on positive aspects of personal 
experience, use rational problem-solving strategies, and seek social support more often 
than the healthy controls.  
Our results show that there is no difference between the means of the two groups. 
However, means of breast cancer patients are significantly different. 
7. Whether breast cancer patients blame others for their problems less than 
healthy controls, to avoid conflict. Breast cancer patients were predicted to have lower 
scores on the WCCL and Blamed Others subscales. 
As our outcomes show, the breast cancer patients have lower scores on WCCL 
and Blamed Others. However, their means of cancer patients are the same as the control 
group.   
69 
In our study, we implied a statistical reviewing of Clement’s responding to 
whether there is any relationship with type C personality and breast cancer.   
1. Does age affect the relationship between cancer and State-Trait Personality? 
Our results show that there is no difference between the mean of breast cancer patients 
and healthy groups. Age does not effect on state-trait personality. 
2. Is there a difference between the means of the cancer and healthy groups with 
respect to State-Trait Personality? 
The statics test under null hypothesis shows the means of both groups are not 
different in state-trait personality. 
Finally, there is no evidence that shows whether there is a relationship between 
breast cancer and type C personality. 
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Chapter 4: 
Parametric Analysis of Pancreatic Cancer 
 
4.1  Introduction 
 The pancreas, a large organ, is found behind the stomach, and it makes and releases 
enzymes that help the body absorb foods, especially fats. Hormones called insulin and 
glucagon are also made in the pancreas and help the human body control sugar levels. 
Tumors or cancer in the pancreas may often grow without any symptoms at first. The 
exact cause of pancreatic cancer is still unknown (U.S. National Library of Medicine 
National Institutes of Health, 2012). An estimated 43,140 adults (21,370 male and 21,770 
female) were diagnosed with non-malignant and malignant pancreas tumors in the United 
States in 2010. Of all the racial/ethnic groups in the United States, African Americans 
have the highest incidence rate of pancreatic cancer. According to the American Cancer 
Society, pancreatic cancer is the fourth leading cause of cancer deaths in the United 
States. This disease continues to be one of the most fatal cancer types, as it spreads 
aggressively and rapidly.  
  In the present study, our goal is to investigate these postulates and to perform 
parametric analysis of cancerous tumor size for genders and races. 
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4.2  The Database  
In the present analysis, we used real data that we obtained from the National Cancer 
Institute’s Surveillance Epidemiology and End Result (SEER) from 1997–2006 
(http://seer.cancer.gov/). The SEER database consists of collected information on 
incidence and survival prevalence and compiles reports on all of these items, plus cancer 
mortality, for the entire United States. In all 24,760 cases of pancreatic cancers analyzed, 
49.31% were males, which included 80.79%  white, 10.37%  African American (AA), 
and 8.84% other races (American Indian/AK native, Asian/ Pacific Islander); and 50.69% 
were females, which included 79.42% white, 11.67% African American, and 8.91% other 
races. Also, 78.66% of deaths were directly associated with pancreatic cancer. Of the 
deceased cases, 9,432 were men, and 9,815 were women. The following diagram, Figure 
4.1, gives a clearer view of the size and classification of the data that we studied.  
 
Figure 4.1 Pancreatic Cancer Data Diagram 
24718 case of 
pancreatic cancer 
Pancreas Cancer 
Cases of death 
19247(78.66%) 
Male 
9432(49.01%) 
 
White 
7663(81.24 %) 
 
 
AA 
962(10.20%) 
 
Others 
807(8.56%) 
Female 
9815(50.99%) 
White 
7894(80.43%)  
AA 
1105(11.26%) 
 Others 
816(8.6 %) 
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Figure 4.1 displays the breakdown of the size, gender, and ethnicity.              
Table 4.1 Discrete Conditional Probability of Malignant Tumor 
pm(malignant | male)≈0.853 
pm(not malignant | male) ≈0.147 
p f ( malignant| female) ≈ 0.874 
pf (not malignant |female)≈0.135  
pm(malignant |AA)≈0.881 
p f (malignant| AA)≈0.895 
pm(malignant |white)≈0.866 
p f (malignant| white)≈0.856 
 
In the present study, we wanted to address the following basic questions on the 
subject matter: 
1. What is the probability distribution that characterizes the pancreatic cancer 
tumor size for females, males, and both sexes together? 
2. Is there a significant difference between female and male mean pancreatic 
cancer tumor size? 
3. Is there a significant difference among the races with respect to the mean size 
of cancer tumor?  
Having a statistical answer to the above questions will give us a better understanding of 
the subject of cancer and guide us toward better strategic planning to address this deadly 
cancer.  
 
4.3  The Probabilistic Behavior of Tumor Size 
To understand the probabilistic behavior of the pancreatic cancerous tumor size, we need 
to statistically search for and identify the probability distribution that best fits the subject 
data. We utilized three goodness-of-fit tests—namely, Kolmogorov-Smirnov (Stephens, 
1974), Anderson-Darling (1952), and Chi-Square (Chernoff & Lehmann, 1954)—to 
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identify the best probability distribution function (pdf) for the subject data. It was found 
for all females that the Gen-Extreme-Value distribution with three parameters (Fréchet) 
was the best-fit probability density function, with the approximate maximum likelihood 
estimates of the parameter given by  ̂= 0.0174,  ̂=1.435, and  ̂=3.54, where k is the 
continuous shape parameter,   is the continuous and positive scale parameter, and   is 
the continuous location parameter. The actual form of the Fréchet probability density 
function is given by 
 ( )   
  
      
   ( (         
      
     
 )
   
       ) (          
      
     
)
   
 
      
, 
and its graph is given below in Figure 4.2: 
 
Figure 4.2 Fitted Gen-Extreme-Value / Fréchet Probability Density Function for Females 
 
For all males, the Dagum Four-Parameter probability distribution function (pdf) 
was found to be the best fit to characterize the pancreatic cancerous tumor size. The 
approximate maximum likelihood estimates of these parameters are  ̂=6.009, ?̂?=34.44, 
 ?̂?=46.15 and 𝛾=-44.83 where ?̂? is the continuous and positive shape parameter, β is the 
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positive continuous scale parameter, and γ is the location parameter. Thus, the Dagum 
probability distribution function is given by 
 
 ( )   
           (
       
     
)             
      ((   (
       
     
)     )
        , (4.2) 
 
   and its graph is shown below in Figure 4.3: 
 
Figure 4.3 Fitted Dagum 4-Parameter Probability Density Function for Males 
 
  The log-logistic probability distribution function with three parameters gave the 
best fit for African American males and white males, with different maximum likelihood 
estimates, as shown in Table 4.2. 
Thus, having identified the probability distribution for the malignant tumor size of 
pancreatic cancer for males and females, we can probabilistically characterize their 
behavior and obtain other useful information, such as expected size of tumor, confidence 
limit, etc. 
Table 4.2 below is a summary of the maximum likelihood estimator (MLE) of 
parameters of the three different probability density functions that characterize gender 
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and ethnicity. We also represent 90% and 95% confidence limits of the true pancreatic 
tumor size for each classification of gender and race. For example, we are least 90% 
certain that the true malignant tumor size of all females between 2.1915 and 6.8140 cm, 
or  
 p (2.1915 ≤ µ ≤ 6.8140) ≥ 90% , (4.3) 
where µ is the unknown true size of the subject tumor. 
Table 4.2 90% and 95% Probabilistic Distribution Confidence Intervals for Gender and Race with 
Mean and Standard Deviation for Variable Tumor Size 
Gender &  
Race 
PDF MLE 90% of CI 
 
95% of CI 
 
Mean 
 
Std-Dev 
 
Female 
 
Gen-Extreme 
Value 
(Frechet) 
  ̂=0.014 
  ̂=1.484 
  ̂=3.422 
 
(2.1915, 6.8146) 
 
(1.8062, 7.9226) 
 
4.4014 
 
1.9391 
 
Male 
 
Dagum -4-
parameters 
  ̂=6.009 
?̂?=34.44 
 ?̂?=46.15 
 𝛾=-44.83 
 
(2.2142, 7.1571) 
 
 
(1.7521, 8.328) 
 
 
4.4944 
 
 
2.0789 
 
AA-Female 
Gen-Extreme 
Value 
(Frechet) 
  ̂=0.1151 
  ̂=1.4962 
  ̂=3.5404 
 
(2.985, 6.9515) 
 
(1.9091, 8.0614) 
 
4.4213 
 
1.9486 
 
White-Female 
 
 
Dagum 
  ̂=0.72162 
  ̂=4.4533 
 ?̂?=4.4351 
 
(2.1865, 6.7212) 
 
(1.7519, 7.9691) 
 
4.3253 
 
2.1322 
 
AA-Male 
 
Log-logistic 
?̂?=5.3413 
 ?̂?=5.7238 
 𝛾=-1.4724 
 
(2.321, 7.1641) 
 
(1.8258, 8.4609) 
 
4.5953 
 
 
2.2201 
 
White Male 
 
 
Log-logistic 
?̂?=5.2074 
 ?̂?=5.6215 
 𝛾=-1.45 
 
(2.2364, 7.1224) 
 
(1.7436, 8.445) 
 
4.5276 
 
 
2.2528 
 
4.4  Comparison of the Mean Tumor Sizes for Gender and Race 
Since our data size is large, we invoke the central limit theorem (CLT) to compare the 
difference between the mean tumor sizes between gender and race.  
We use the following notations, μ f, μ m, μ f AA, μ f w, μ m AA, and μ mw, to represent 
the true population mean tumor size for females, males, white females, African American 
females, African American males, and white males, respectively. The results are shown 
in Table 4.3 below. 
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Table 4.3 Test Hypothesis for α= 5% Significance Level for Mean of Tumor Size 
Significance Level  of  α = 5% Decision 
H0:     μ f = μ m vs.   H1: μ f ≤ μ m Reject 
H0:     μ f AA = μ f w vs.   H1:  μ f w  ≤ μ f AA Reject 
H0:     μ m AA = μ mw vs.  H1:  μ m AA ≤ μ mw            Fail to Rejected 
 
 Thus, the mean of tumor size between genders is significantly different in favor of 
the male tumor size being larger at α = 5% level of significant with a p-value < 0.0001. 
Also, non-parametric testing using Kruskal-Wallis supports the current decision. Further, 
the analysis reveals that the tumor sizes of the white females are smaller than those of the 
African American females. However, we failed to reject the hypothesis at α = 5% that the 
true size of African American male tumors is the same as white male tumors. 
  
4.5  Summary 
 In the present study, we identified probabilistic distribution that characterizes the tumor 
size of pancreatic cancer tumors in males, females, whites, and African Americans. Table 
4.4 below summarizes the probability distribution function (pdf) for each case. 
Table 4.4 Probability of Distribution Genders and Races  
Genders  
& Race 
Female Male AA-
Female 
White 
Female 
AA-male White 
male 
PDF Frechet Dagum(4P) Frechet Dagum(3P) Log-
logistic 
Log-
logistic 
 
In addition, we have shown that the true mean size of the malignant tumor for 
females is smaller than it is for males, smaller for white females than for African-
American females, and the same for white males as for African-American males.  
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Chapter 5: 
Statistical Modeling of Pancreatic Cancer Tumor Size as Function of Age 
                  
5.1  Introduction 
The pancreas, a large organ, is found behind the stomach, and it makes and releases 
enzymes that help the body absorb foods, especially fats. Hormones called insulin and 
glucagon are also made in the pancreas and help the human body control sugar levels. 
Tumors or cancer in the pancreas may often grow without any symptoms at first. The 
exact cause of pancreatic cancer is still unknown (U.S. National Library of Medicine 
National Institutes of Health, 2012). An estimated 43,140 adults (21,370 male and 21,770 
female) were diagnosed with non-malignant and malignant pancreas tumors in the United 
States in 2010. Of all the racial/ethnic groups in the United States, African Americans 
have the highest incidence rate of pancreatic cancer. According to the American Cancer 
Society, pancreatic cancer is the fourth leading cause of cancer deaths in the United 
States. This disease continues to be one of the most fatal cancer types, as it spreads 
aggressively and rapidly.  
In the present study, our goal is to investigate the effect of age on pancreatic 
cancer tumor size for genders and races. 
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5.2  The Database  
In the present analysis, we used real data that we obtained from the National Cancer 
Institute’s Surveillance Epidemiology and End Result (SEER) from 1997–2006 
(http://seer.cancer.gov/). The SEER database consists of collected information on 
incidence and survival prevalence and compiles reports on all of these items, plus cancer 
mortality, for the entire United States. In all 24,760 cases of pancreatic cancers analyzed, 
49.31% were males, which included 80.79%  white, 10.37%  African American (AA), 
and 8.84% other races (American Indian/AK native, Asian/ Pacific Islander); and 50.69% 
were females, which included 79.42% white, 11.67% African American, and 8.91% other 
races. Also, 78.66% of deaths were directly associated with pancreatic cancer. Of the 
deceased cases, 9,432 were men, and 9,815 were women. 
As our pervious study on pancreatic cancer tumor showed, the mean of pancreatic 
tumor sizes differed significantly between genders (Kottabi & Tsokos, 2012). In addition, 
for females, the mean tumor size was different between white and African American 
races. Several risk factors that are known affect an individual’s probability of developing 
pancreatic cancer. Some of these, such as age, cannot be changed. As shown in Graph 
4.1, the incidence of pancreatic cancer increases intensely with age. Pancreatic cancer is 
rare in people under the age of 50, with less than 8% of all cases diagnosed in this 
bracket. The highest incidence is between the ages of 70 and 79, and 73% of all cases of 
pancreatic cancer occurring in people between the ages of 50 and 79. 
  
77 
                                                                Percent                                                                                                  
                   | 
          <25      |                                               0.06     
                   | 
         20-29     |                                               0.19    
                   | 
         30-39     |*                                              1.09      
                   | 
         40-49     |******                                         5.68    
                   | 
         50-69     |*****************                              15.13   
                   | 
         60-69     |****************************                   25.16    
                   | 
         70-79     |************************************           32.08    
                   | 
         80-89     |********************                           17.79    
                   | 
         90-99     |***                                             2.77   
                   | 
         >100      |                                                0.04    
                   | 
                   |_____|____|____|____|____|_____|_____|___ 
                       1000 2000 3000 4000 5000 6000 7000 
Figure 5.1 Bar Graph Relative Frequency Ages of Pancreatic Cancer Patients 
 
The goal of this present study is to answer several questions: 
• Is there any relationship between age and pancreatic cancerous tumor size?  
• Is this relationship for all races and genders the same? 
• What is the effectiveness of age on the grow rate of pancreatic cancer tumor 
size? 
To answer these questions, differential equations must be developed that characterize the 
behavior of the tumor as a function age by studying the mathematical model of the 
growth of pancreatic cancer tumor size as a function of age. In the present analysis, 
19,247 of pancreatic cancer patients were selected by Kottabi and Tsokos (2012) and 
introduced in Parametric Analysis of Pancreatic Cancer.  
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5.3  Male Pancreatic Cancer Tumors and Age 
From the SEER data, 7,424 African-American and white male pancreatic cancer patients 
from ages 30 to 100 were selected (Kottabi & Tsokos, 2012). Figure 5.2 shows the scatter 
diagram of averaging pancreatic cancer tumor sizes as a function of age for African 
American and white males. 
 
Figure 5.2 Mean of Malignant Pancreatic Cancerous Tumor Size for Male 
 
As seen in Figure 5.2, approximately every three or four years of age, the graph has a 
turning point, which makes it difficult to calculate the differential equation mean of 
tumor size as a function of age. Thus, to avoid the difficulty of calculation, the data 
analysis is focused on taking the average of the tumor size in intervals of four years of 
age, as shown in Figure 5.3. 
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Figure 5.3 Mean of Tumor Size in Interval of Four Years of Age 
 
5.3.1 Mathematical Model 
Let a stand for male pancreatic cancer patients’ age in terms of years, and the 
corresponding tumor size is a function of age ( T (a)) in millimeters (mm), then the rate 
of the tumor size ( T`(a)) is the derivative of the function T(a). 
The mathematical function that characterizes male pancreatic cancer tumor size 
behavior in the given age is expressed in the following polynomial 5.1: 
   ̂(a) =6.4668 - 0.06261 a + 1.335* 10-4  a3 – 9.61505* 10-8  a4.     (5.1) 
Table 5.1 shows the quality and the residual analysis of the mathematical function that 
characterizes male pancreatic cancer tumor size behavior by age.  
Table 5.1 Male Residual Analysis of Pancreatic Cancer Tumor Size 
 
Sum of Residuals                                    7.2572E-13 
Sum of Squared Residuals                      0.12577 
Predicted Residual SS (PRESS)             0.71243 
R-Square                                                 0.86 
Adjusted-R Square                                  0.84 
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Figures 5.4 and 5.5 display the QQ plot of the residual mean of pancreatic tumor size and 
predict the value for males aged 53 to 63.        
 
  
 
Figure 5.4 Male: QQ Plot of Residual Analysis of Pancreatic  
Cancer Tumor Size 
 
 
Figure 5.5 Male: Plot of Predicted Mathematical Model of Pancreatic Cancer  
Tumor Size and T (a) for Age 53 to 63 
 
Equation 5.6 shows a derivative of measuring the change of mean tumor size when the 
age changes.    
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  ̂   
  
   ̂`(a) = - 0.06261 + 4.005* 10-5  a2 – 3.84602* 10-7  a3     (5.2) 
To evaluate the accuracy of the results on Equation 5.3, a classical rate of change (CRC) 
of mean tumor size with respect to age is obtained from  
                                   
                                                 
                    
    (5.3) 
Table 5.2 displays comparison results of Equations 5.2 and 5.3 for ages 53 to 63. 
 Table 5.2 Residual Analysis of Rate Change of Mean of Pancreatic Cancer and T`(a) 
Age Tumor Rate of Change Rate= T`(a) Rate of 
residual 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
4.22069 
4.21597 
4.27769 
4.44122 
4.41090 
4.64691 
4.42810 
4.25510 
4.17318 
4.31489 
 
-0.02835 
-0.00112 
0.01464 
0.038229 
-0.00683 
0.053506 
-0.04709 
-0.03907 
-0.01925 
0.033957 
 
-0.00639 
-0.00545 
-0.00456 
-0.00371 
-0.00292 
-0.00219 
-0.0015 
-0.00088 
-0.00032 
0.00018 
0.02197 
-0.00433 
-0.0192 
-0.04194 
0.003905 
-0.05569 
0.045583 
0.038187 
0.018933 
-0.03378 
 
 
Mean of Residuals  Error                                                  -0.00264 
Standard Error of Residuals                                               0.034499 
 
 
Figure 5.6 shows the rate of changing mean size of a growing pancreatic cancer tumor 
when the age of the patient increases from 53 to 63. 
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Figure 5.6 Rate of Pancreatic Cancer Tumor Size Age 53 to 63 
 
As seen from the result of Table5.2, the residual is small and so is the standard error. 
These results indicate a good quality of model for the mean of tumor size. 
 
5.4  African-American and White Female Pancreatic Cancer Tumor vs. Age 
The previous chapter showed that pancreatic cancer has a larger rate of incidence in 
female patients than in male patients. Moreover, as the result showed in the previous 
study (Kottabi & Tsokos, 2012), for African-American and white females, the mean of 
pancreatic tumor size is significantly different. Thus, the information about female 
patients is distinguished by race: African Americans and whites.  
 
5.4.1  African-American Female Pancreatic Cancer Tumor vs. Age 
The data consists of 1,105 African-American female patients from ages 20 to 96. 
Previous results have shown that the mean of tumor size in African-American female 
pancreatic cancer patients is smaller, and the rate of tumors found to be malignant is 
higher than in white females. Figure 5.7 shows the scatter plot of the mean of tumor size 
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for African-American females, as a function of age, which died from this particular 
cancer. 
 
Figure 5.7 AA-Female Mean of Pancreatic Cancer Tumor vs. Age 
 
As seen Figure 5.7, about every three or four years of age, the graph has a turning point. 
Thus, for better analytical characterization, the data analysis is focused on taking the 
average size of the tumor in intervals of four-year increases in age. To obtain a better 
mathematical model for the function of tumor versus age, the outliers’ data are eliminated 
for ages less than 34 or greater than 97. The mathematical function that clarifies the 
pancreatic cancer tumor size behavior in the given age for African-American females is 
expressed in the following polynomial 5.4: 
  ̂ (a) = 40.00456 – 1.22340 a + 169.12248 log 
 
 
 + 186.47505 a1/3. (5.4) 
tumor
2
3
4
5
6
7
8
age
20 30 40 50 60 70 80 90 100 110
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Checking the quality of the model fit by residual analysis of the pancreatic cancer tumor 
is shown in the following Table 5.3: 
 
Table 5.3 AA-Female Residual Analysis of Pancreatic Cancer Tumor Size 
 
Sum of Residuals                                    -2.9857* 10
-12
 
Sum of Squared Residuals                        0.87977 
Predicted Residual SS (Press)                   1.75450 
R-Square                                                    0.89 
Adjusted-R Square                                     0.87 
 
 
Figure 5.8 displays a graph of mean pancreatic cancer tumor size as a function of age and 
the mathematical predicted value of tumor versus age for African-American females.  
 
 
Figure 5.8 AA-Female: Plot of Pancreatic Cancer Tumor Size Age 47 to 62 
 
Equation 5.5 shows a derivative of measuring change of mean tumor size when the age 
changes.    
 
  ̂   
  
  ̂ `(a) =  -1.2234 -  
         
 
 + 
         
 
 a-2/3  (5.5) 
tumor
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To evaluate the accuracy of the results in Equation 5.1, a rate of change of mean tumor 
size with respect to age is obtained from the rate of change shown in Equation 5.3 (CRC). 
The comparison results of Equations 5.4 and 5.5 for ages 48 to 62 that can evaluate the 
quality of the model fit by residual analysis of pancreatic cancer tumor is displayed in 
Table 5.4. 
Table 5.4 Residual Analysis of Rate Change of Mean of Pancreatic Cancer and T`(a) 
Age Tumor T`(a) CRC 
Residual 
Rate     
48 3.89 -0.04056759 0.322379603 0.362947195 
49 4.6142857 -0.03291173 0.1861917 0.219103433 
50 4.1222222 -0.02598321 -0.10663915 -0.08065593 
51 4.2375 -0.01972558 0.02796496 0.047690537 
52 5.0285714 -0.01408741 0.186683523 0.200770929 
53 4.5888889 -0.0090218 -0.08743687 -0.07841507 
54 4.9454545 -0.00448591 0.077701959 0.082187871 
55 4.61 -0.00044054 -0.06783088 -0.06739034 
56 4.5782609 0.003150214 -0.00688484 -0.01003506 
57 3.9833333 0.006319303 -0.12994619 -0.13626549 
58 3.9608696 0.009096983 -0.00563944 -0.01473642 
59 4.2652174 0.011511081 0.076838639 0.065327558 
60 3.855 0.013587217 -0.09617737 -0.10976459 
61 4.3541667 0.015349011 0.129485517 0.114136505 
62 4.375 0.016818257 0.004784689 -0.01203357 
 
Mean of Residual Rate (Error)                             0.038857838 
 
Standard Error of Residuals                                       0.139385 
 
Figure 5.9 shows the rate (T`(a)) the pancreatic cancer tumor is growing when the age of 
African-American females from 48 to 62 increases. As revealed in Table 5.4, the rate 
T`(a) is not constant. For instance, the rate of the growing mean tumor for patients aged 
47 to 48 (0.322379603) is more than the tumor rate for patients ages 57 to 58(-0.005639). 
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Figure 5.9 Rate of Pancreatic Cancer Tumor Size Ages 48 to 62 
 
Figure 5.10 displays the QQ plot of the residual mean of pancreatic tumor size and 
predicted value for African-American females ages 47 to 62.      
Figure 5.10 AA Females: QQ Plot of Residual Analysis of Pancreatic Cancer Tumor Size 
 
As seen from the results of Table 5.4, the residual is small and so is the standard error. 
These results attest to the decent quality of model for the mean of tumor size. 
 
 
 
rate
-0.05
-0.04
-0.03
-0.02
-0.01
0.00
0.01
0.02
age
48 49 50 51 52 53 54 55 56 57 58 59 60 61 62
87 
5.4.2  White Female Pancreatic Cancer Tumor vs. Age 
It has been shown in Figure 5.1 that 51% of pancreatic cancer patients are females who 
are deceased from pancreatic cancer, which includes 80% white female pancreatic cancer 
patients. Previous results have shown that the mean of tumor size in white female 
pancreatic cancer is larger than in African-American females, and the rate of their mean 
of tumor to be malignant is lower than in African American females. Figure 5.11 shows 
the scatter plot of the mean of tumor size as a function of age for the white female 
pancreatic cancer patients who are deceased because of this particular cancer. 
 
Figure 5.11 Mean Pancreatic Tumors vs. Age for White Females 
 
As displayed in Figure 5.11, about every four years of age, the graph has a turning point. 
Thus, for better investigative characterization, the data analysis is focused on taking the 
average tumor size in intervals of four-year increases in age. To obtain a better 
mathematical model for the mean pancreatic cancerous tumor as a function of age, the 
outliers’ data are eliminated for early ages less than 30. 
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The mathematical function that clarifies the pancreatic cancer tumor size behavior 
in the given age for white females follows in polynomial 5.6: 
  ̂ (a) = 76.61776 + 1.2918 a – 0.00339 a2 – 32.71483 a1/3     (5.6) 
Figure 5.12 displays a graph of the mean pancreatic cancer tumor size as a function of 
age and the mathematical predicted value of tumor versus age for white females.  
 
Figure 5.12 White-Females: Plot of Pancreatic Cancer Tumor Size Age 30 to100 
 
The quality of the model fit is checked by a residual analysis of the pancreatic cancer 
tumor, as shown in the following Table 5.5:  
Table 5.5 White Female Residual Analysis of Pancreatic Cancer Tumor Size 
 
Sum of Residuals                                     0.00 
Sum of Squared Residuals                       0.22319 
Predicted Residual SS (Press)                  0 .63869 
R-Square                                                   0.83 
Adjusted-R Square                                    0.80 
 
            
 
To investigate the rate of growth for the mean of tumor size for white females, Equation 
5.6 is used, which is obtained from the derivative Equation 5.7. 
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  ̂   
  
  ̂ `(a) =  1.12918 – 0.00678 a -  10.9049433a-2/3  (5.7) 
To evaluate the accuracy of the results in Equation 5.7, a classical rate of change of the 
mean tumor size with respect to age is obtained from the rate of change that is shown in 
Equation 5.6. The comparison results of Equation 5.7 and the classical rate for ages 48 to 
62 that can evaluate the quality of the model fit by residual analysis of the pancreatic 
cancer tumor is displayed in Table 5.6.  
Table 5.6 Residual Analysis of Rate Change Mean of Pancreatic Cancer  
Tumor (CRC) and T`(a) 
Age T` (a) CRC Residual 
              46 0.124751 0.033148 
 
-0.0916 
47 0.130508 -0.11201 
 
-0.24252 
48 0.13582 0.098064 
 
-0.03776 
49 0.14071 -0.01532 
 
-0.15603 
50 0.145202 0.038274 
 
-0.10693 
51 0.149317 -0.04773 
 
-0.19705 
52 0.153075 0.1298 
 
-0.02327 
53 0.156493 -0.05981 
 
-0.21631 
54 0.159591 -0.05056 
 
-0.21015 
55 0.162382 0.008742 
 
-0.15364 
56 0.164882 0.007646 
 
-0.15724 
57 0.167105 0.03783 
 
-0.12928 
58 0.169065 -0.00752 
 
-0.17658 
59 0.170772 -0.0951 
 
-0.26587 
60 0.172239 0.087696 
 
-0.08454 
61 0.173477 0.023719 
 
-0.14976 
62 0.174494 -0.01031 
 
-0.18481 
63 0.175302 -0.04902 
 
-0.22432 
64 0.175908 0.013277 
 
-0.16263 
65 0.176321 -0.00344 
 
-0.17977 
66 0.176549 0.060446 
 
-0.1161 
67 0.1766 -0.04825 
 
-0.22485 
68 0.176481 0.050697 
 
-0.12578 
 
Mean of Residual 
Rate (Error)                               
 
                                       -0.15327 
Standard Deviation  
of Residual                                        0.062131 
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As seen in Figure 5.13, the rate (T`(a)) of the pancreatic cancer tumor is growing when 
the age of white females aged 45 to 68 is increasing. As displayed from Table 5.6, the 
rate T` (a) is not constant. To illustrate, the rate of the growing mean tumor for ages 47 to 
48 is 0.005757, but the mean tumor rate from ages 56 to 57 is 0.002223. 
 
 
 
Figure 5.13 White Female Rate of Pancreatic Cancer Tumor Size Age 45 to 68 
 
 
Figure 5.14 White Female QQ Plot of Residual Analysis of Pancreatic Cancer Tumor Size  
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As seen from the results of Table 5.6 the residual is small and so is the standard error. 
These results indicate a good quality of model for the mean of tumor size. 
 
5.5  Conclusion 
The following is shown from our statistical analysis  results of all genders and races: 
 The mathematical models for males and African-American and white females are 
unlike. One has a polynomial function and the others have a combination of linear 
and nonlinear functions.  
 All three mathematical models have shown that the rate of mean pancreatic cancer 
(T`(a)) is growing faster when the age increases. 
 As the rate (T`(a)) is not constant in any of these models, the attention in future 
studies should be to look for the other variables that affect the pancreatic cancer 
tumor size. 
 Finally, developing a differential equation that can be used to obtain the rate of 
growth for malignant tumor size and justified the mathematical behavior function 
of age by residual analysis. 
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Chapter 6: 
Parametric and Nonparametric Survival Analysis of Pancreatic Cancer 
 
6.1 Introduction 
        Survival analysis is a branch of statistics that deals with death in biological 
organisms and failure in mechanical systems. Scientists have used a variety of parametric 
functions to approximate the distribution of survival times of a patient who survived 
cancer under study. Given a set of failure (survival) time, t1, t2, t3… tn, the survival 
function is defined by    ( )    (   )    ∫  ( )   
 
  
  t ≥ 0,               (6.1) 
where f(T ) is the failure probability distribution function(pdf) that characterizes the 
probabilistic behavior of the survival times.  
The survival time’s data of pancreatic cancer patients that we will use in the 
present study were taken from Surveillance Epidemiology and End Result (SEER) from 
1997–2006 (http://seer.cancer.gov/). The SEER database consists of collected 
information on incidence and survival prevalence and compiles reports on all of these 
items, plus cancer mortality, for the entire United States. The data collection includes 
22,596 pancreatic cancer patients with 4,487 right-censored information. Also, the data 
contains 2,518 African Americans with 544 right-censored information and 18,093 
whites with 3,501 right-censored information. In this present study, the data of the 
survival time was converted to months for statistical convenience and practical relevance 
in all statistical analyses.  
The following diagram, Figure 6.1, gives a clearer view of the size and the true 
mean of survival times with respect to gender and ethnicity.    
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Figure 6.1 SEER Survival Time Data for Pancreatic Cancer Patients 
The pancreatic cancer data as shown in the schematic diagram 6.1 will be used for 
statistical analysis in the present study.   
For conjectural purposes, when we considered the female survival data alone, we 
found that the true mean of survival time of whites and African Americans differed. 
Moreover, for male survival time data alone, we observed that the true mean of survival 
time of whites and African Americans differed. However, we found that the true mean of 
survival time between males and females was the same. Thus, we combined the female 
and male survival time data together, which is shown in Figure 6.2.  
 
 
 
 
 
Pancreactic cancer 
Patients 
22,596 
 
Male 11,276 
(𝑥 𝑠𝑢𝑣=8.45month) 
 
Whites  9,112 
(𝑥 𝑠𝑢𝑣=8.68month) 
 
African Americans 1180 
(𝑥 𝑠𝑢𝑣=6.83month) 
Others 984 
(𝑥 𝑠𝑢𝑣=8.25month) 
Female  11,320 
(𝑥 𝑠𝑢𝑣=8.47month) 
 
 
Whites 8981 
(𝑥 𝑠𝑢𝑣=8.55month) 
 
 
 
 
African Americans 1,338 
(𝑥 𝑠𝑢𝑣=7.43month) 
 
 Others 1,001 
(𝑥 𝑠𝑢𝑣=8.77month ) 
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Figure 6.2: SEER Survival Time Data for Pancreatic Cancer Patients for Races 
More specifically, we will address the following questions: 
 Is there a significant difference of true mean survival time with respect to males 
and females with respect to races? 
 Is there a significant difference of true mean survival time among African 
Americans, whites, and others? 
 Is parametric survival time possible? 
 How effective is it if we propose the kernel density approach to survival analysis? 
 How good is the popular Kaplan Meier survival analysis when compared with 
others (parametric and nonparametric functions)? 
 Does the Cox PH survival analysis provide any additional information with 
respect to survival function? 
 How is the hazard of the COX PH function different from the survival function? 
 
 
 
Pancreatic Caner patients 
22,596 
African Americans 2,518 
𝑥 =7.32 
 
Whites 18,093 
𝑥 =8.60 
 
Others 1,985 
𝑥 = 8.52 
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6.2 Basic Statistical Survival Time Analysis for Genders and Races  
We discussed the subject database in detail and the schematic network diagram of the 
complete database. In addition, we performed the statistical analysis to determine any 
differences that may exist among genders and races. 
The performance of the statistical tests of over 22,596 cases of pancreatic cancer 
that contain 11,276 males and 11,320 females for the mean of survival times between 
genders with respect to races for α= 5% level of significance is shown in Table 6.1.  
Since our data size is large, we invoked the central limit theorem (CLT) for parametric 
tests to compare the difference between the mean survival times between genders and 
ethnic groups (Harrington & Fleming, 1982). Also, nonparametric testing using Kruskal-
Wallis supports the current decision (Anderson & Darling).The following notations μ f, 
 μ m, μ f AA, μ f w, μ m AA, μ mw, μ  AA, μ w, and μ others represent the true population mean 
survival times for females, males, white females, African-American females, African-
American males, white males, African Americans, whites, and others, respectively. The 
results are shown in Table 6.1 below. 
Table 6.1 Test Equality Survival Times between Genders and Races 
Significance Level  of  α = 5% Decision 
H0:     μ f = μ m vs.   H1: μ f ≤ μ m 
Fail to 
Reject 
H0:     μ f AA = μ m AA vs.   H1: μ f AA ≤ μ m 
AA 
Fail to 
Reject 
H0:     μ f w = μ m w vs.   H1: μ f w ≤ μ m w 
Fail to 
Reject 
H0:     μ f AA = μ f w vs.   H1:  μ f w  ≤ μ f AA Reject 
H0:    μ m AA = μ mw vs.  H1:  μ m AA ≤ μ mw                        Reject
 H0:   μ other = μ w = μ AA vs.  
 H1:  At least one of true means is not 
equal                              
Reject 
H0:    μ AA = μ w vs.  H1:  μ  AA ≤ μ w Reject 
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Thus, based on our initial statistical analysis of the pancreatic cancer data that is shown in 
Figures 6.1 and 6.2 and Table 6.1, we can conclude that  
 There is no significant difference in the average survival times in months between 
males and females. 
 There is no significant difference in the true mean of survival times in months 
between African-American males and females. 
 There is no significant difference in the average survival times in months between 
white males and females. 
 There is a significant difference in the average survival times between male 
whites and male African Americans. 
 There is a significant difference in the true mean of survival times between female 
whites and female African Americans. 
 There is a significant difference in the true mean of survival times among whites, 
African Americans and others. 
 There is a significant difference in the true mean of survival times among whites 
and African Americans. 
As a result of the diagrams 6.1 and 6.2 and statistical analysis performance of Table 6.1 
in terms of the difference between African Americans and whites, in the next sections we 
will proceed to perform a parametric statistical analysis. However, in our study we did 
not consider the others race since others race is mixed of different races. 
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6.3 Probability of Survival Times 
This section attempts to find the probability distribution that characterizes the behavior of 
the survival times of the pancreatic cancer patients and discuss its usefulness in addition 
to having this distribution for performing parametric survival analysis. The study 
continuous to perform the survival analysis models that we discussed above, along with 
the corresponding hazard function.  
To identify the best probability distribution failure time, multiple fitting 
distributions are performed at the same time. The Kolmogorov-Smirnov (KS) statistical 
goodness-fit test is used to classify the probability distribution function (pdf) that 
characterizes the probability behavior of survival times (Anderson & Darling) for each 
race and for both races together. The best-fitted parametric distribution of survival 
analysis respective to races is shown in Table 6.2.  
Table 6.2 Evaluation the Best Fitted Probabilistic Distribution for AA, 
White and Both Races 
RACE PDF KS Parameter (standard error) 
AA Pareto 
3.83353*  ̂= 5.06719(0.42543) 
 ̂= 1.03559( 0.05593) 
White Pareto 
8.43129*  ̂= 7.46665 (0.23726) 
 ̂= 1.19857 (0.00686) 
Both 
Races 
Pareto 
9.23786*  ̂= 7.11289 (0.21130) 
 ̂= 1.17530 (0.02318) 
 
 
Table 6.2 indicates the probability distributions, statistical fit test, distributions’ 
parameter estimations and the estimations’ standard errors for African Americans (AA), 
whites, and both ethnic groups together. In addition, the best fitting probability 
distribution for survival times is the Pareto distribution for African Americans, whites, 
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and both races together. The statistical computations in the next section are based on the 
distributions’ parameters. 
 
 Pareto Distribution  
Pareto distribution is demonstrated with skewed and heavy-tailed distribution. In 
applications, the heavy-tailed distribution is an essential tool for modeling extreme loss, 
especially for risky times of survival the cumulative distribution function (CDF) of Pareto 
is given by 
    ( )    (
 
   
)
 
                (6.2),  
where α is the continuous shape and θ is the scale parameter respectively. 
The estimation parameters obtained by using the method of moments where 
   [ ]           [ 
 ]     ,        (6.3),    
   ̂  
    
 (     
  )
 , and  ̂  
 (     
  )
(      
  
)
           (6.3), 
where α is the shape parameter and θ is the scale parameter of the Pareto distribution. 
The survival function of the Pareto distribution is given by   
     (t; α, θ) = (
 
   
)
 
, where α > 0 and θ > 0.        (6.4), 
The parametric estimations of the survival and hazard functions for African Americans 
(AA), whites, and both races together (BR) are given by the following: 
 African American (AA)                  
   ̂   (t; α, θ) = (
       
         
)        (6.5) 
   ̂ ( )     (
       
         
)             (6.6) 
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 White Race 
   ̂ (t; α, θ) = (
       
         
)              (6.9) 
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 Both Races (BR) 
   ̂   (t; α, θ) = (
       
         
)            (6.13) 
   ̂  ( )    (
       
         
)                 (6.14) 
   ̂  ( )  
(       )              
(         )       
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(       )              
(         )       
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)       
               (6.16)     
 
6.4 Kernel Density Estimation  
It is possible to identify the probability distribution of survival analysis and characterize 
the behavior of survival time incorrectly, or it is possible that the goodness-of-fit test 
methodology failed to classify a classical probability distribution. Thus, proceeding with 
the survival analysis in this way may result in misleading and incorrect results. One of the 
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methods is based on estimating failure density through the concept of distribution-free 
kernel density method (Cox, 1972). 
 Let t1, t2… tk be independent and identically distributed samples of a random 
variable, and then the nonparametric probability kernel density estimate  ̂ ( )can be 
written as  
   ̂ ( )  
 
  ̂
∑  (
    
 ̂
 
   )    (6.17), 
where K is the kernel and  ̂ is the estimate of the optimal bandwidth (Young and P. 
Tsokos 2010). 
To obtain the best kernel density estimation (KER), a combination of different 
kernels and optimal bandwidths is attempted intended. The best experimental result was 
an Epanechnikov where  ̂ is a normal optimal bandwidth with respect to survival time 
data of each race and both races together, as shown in equations 6.18 and 6.19 
  ( )  
 
 
(    )       (|y|≤ 1) (6.18) 
   ̂  
       (      )
      
 
 
 
       (6.19), 
where SD is the sample standard deviation and IQR is the sample interquartile-range. 
The kernel density of survival function is given by 
   ̂ ̂( )  ∑
 
  ̂
∑  (
    
 ̂
 
   )    (6.20). 
In this equation, K is the kernel and  ̂ is a normal optimal bandwidth where  ̂ is obtained 
from equation 6.19. 
    ̂( )  
 
  ̂
∑  (
    
 ̂
 
   )
   ∑
 
  ̂
∑  (
    
 ̂
 
   )   
    (6.21) 
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To compare the estimations between the survival kernel function ?̂? (𝑥) and the Pareto 
function in a graph, a residual analysis is achieved for African Americans, whites, and 
both races together. 
 African American 
As can be seen in Figure 6.3 for the first 15 months, the estimation survival 
function with the kernel model is about the same as the Pareto survival function. 
However, at the heavy tail of the graph we can see that the probability survival kernel 
function is increasing and goes above the Pareto survival function, but they are not too far 
from each other.  
 
Figure 6.3 Graph of Survival Functions Method of KER and Pareto for AA 
 
 Residual Analysis 
The residual analysis result shows that the difference between the kernel survival 
function and the Pareto survival function is minor. Also, the computation of residual 
analysis indicates that the mean of residual probability is 0.03024; its standard deviation 
is 0.02274, with a standard error of 0.00143.  
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 Whites  
Figure 6.4 displays a comparison graph of parametric survival function (PD) and 
kernel survival function. For first months, it is hard to distinguish from each other. 
However, later, in about 12 months these graphs start to get split from each other in an 
evident manner.  
 
Figure 6.4 Comparison Survival Functions with Method of KER and PD for White Race 
 
 Residual Analysis 
To obtain the difference between these two functions, a residual analysis was 
performed. The residual analysis result shows that the mean of residual probability is 
0.02495; its standard deviation is 0.01837, with a mean square error of 0.00096. Thus, the 
difference between the kernel survival function and the Pareto survival function is minor.  
 Both Races 
As can be seen in Figure 6.5, the graphs of parametric distribution (PD) and 
kernel survival function can be distinguished from each other. However, during the first 
months it is hard to differentiate them from each other. Moreover, after 40 months, the 
kernel survival function is increasing and gets higher survival probability than the Pareto 
survival function. 
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Figure 6.5 Survival Functions with Method of KER and PD 
 
 Residual Analysis 
The result of residual analysis difference between these functions shows that the 
mean of residual probability is 0.02555; its standard deviation is 0.01891, with a standard 
error of 0.0010104. Thus, the difference between the kernel survival function and the 
Pareto survival function is trivial.  
 Summary 
It has been shown in all three Figures 6.3, 6.4, and 6.5 that, for the earliest 
months, the graphs of survival functions of kernel and Pareto are about the same, and 
later these graphs are better distinguished from each other. However, the Figure 6.3 for 
African American shows that the probability survival function is decreasing faster than 
whites’ survival function. For instance, at around 10 months, the survival function for 
whites is about 40% and 39% respectively to Pareto and kernel functions, but for African 
American it is about 37% and 36% respectively to Pareto and kernel functions. All 
residual analyses indicate a trivial difference between kernel and Pareto survival 
functions. 
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6.5 Nonparametric Estimates of the Survival and Hazard Functions 
Nonparametric is a method used when the probability distribution of survival analysis 
and characterized behavior of survival time does not identify. In this case, to identify 
nonparametric survival analysis, we will proceed with nonparametric methods of Kaplan 
Meier and COX PH to study the subject matter. 
 
6.5.1 Kaplan-Meier Method 
Kaplan-Meier analysis is used to analyze how a given population evolves with time. The 
probability that an item from a given population will have a survival time exceeding t is 
the survival function S (t). Let us consider a random sample of size k of the failure 
observed times until death, that is t1, t2, t3, …, tk, such that t1 ≤ t2 ≤ t3 ≤ …, ≤ tk-1 ≤  tk, 
where nj is the number of patients at risk just prior to time t j, and let d j be the number of 
deaths at exact time t j (Kaplan & Meier, 1985). 
Survival function can be estimated directly from the continuous survival failure 
times is given by the function 
    ̂( )  ∏
     
  
          ,      t 1 ≤ t ≤ t k (6.22) 
 ̂( ) is defined by the estimated survival function of either 1 if the jth case is uncensored 
(complete), and 0 if it is censored. The estimate of cumulative Hazard function is given 
by  
  ̂( )      ( ) (6.23) 
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 Kaplan Meier (KM) and Parametric (CDF) Models 
Table 6.3 displays basic information of survival time function of SEER pancreatic 
cancer patients with respect to African Americans, whites, and both races together. 
   Table 6.3 Analysis of Kaplan Meier Survival Time on Pancreatic Cancer Patients 
Races Total Failed Censored Mean Standard Error 
African 
American 
2,518 1,974 544 10.9582 0.4014 
White 18,093 14592 3,501 11.8291 0.1414 
Both 22,596 18148 4,448 11.6871 0.1325 
 
To evaluate the difference in survival function between the Kaplan Meier function and 
the parametric function, a residual analysis is achieved with respect to each race and then 
both together. 
 African American 
As can be seen, Figure 6.6 displays the graphs of the Kaplan-Meier (survival) and 
Pareto survival functions at the same time. It is clear that, for the first months, these 
functions have the same estimates of survival time. However, at about eight months, 
these graphs can be distinguished from each other, and it becomes evident that the KM 
function is reaching a higher percentage of survival probability than the Pareto function.    
 
                                     Figure 6.6 Survival Function Methods of KM and Pareto for AA 
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To evaluate the difference between the KM and Pareto curves, a residual analysis was 
calculated. The result of analysis shows that the mean residual is -0.04543, with a 
standard deviation of 0.01632 and a mean square error (MSE) of 0.00234. 
 
 Whites 
  A graph of the Kaplan-Meier estimation (survival) and parametric survival 
function (Pareto) curve is shown in Figure 6.7, which indicates that the probability 
survival function for KM in the first months is higher than the parametric function, and 
later the difference between these two curves is increasing.     
 
Figure 6.7 Survival Functions Method of KM and PD for Whites 
 
To compare the variance between the KM and Pareto curves, the residual analysis 
was calculated. The result of analysis shows that the mean of residual is -0.03672, with a 
standard deviation of 0.05732 and a mean square error of 0.00463. 
 
 Both Races 
Figure 6.8 presents the graphs of the Kaplan-Meier survival function and the 
Pareto survival function (PD). It is obvious in Figure 6.8 that theses curves are not 
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identical. Thus, a residual analysis can estimate the difference between these curves.   
 
Figure 6.8 Comparison Survival Functions with Method of KM and PD for both Races 
 
To compare the KM survival curve with the Pareto distribution models, the residual 
analysis is performed. The result shows that the mean of residual is -0.03859, with a 
standard deviation of 0.05958 and a mean of square error of 0.00504.   
 Summary  
  Table 6.4 displays a residual summary of comparing the survival analysis of the 
KM function and parametric distribution function with respect to race. For all races, the 
KM function has a higher rate of survival time.    
Table 6.4 Residual Analysis of KM Survival Time on Pancreatic Cancer Patients 
Race Mean Error Standard Error Mean square Error 
African American - 0.05015 0.07384 0.00796 
White - 0.03672 0.05732 0.00463 
Both - 0.03859 0.05958 0.00504 
        
6.6 Cox’s Proportional Hazards Regression  
A different approach to the standard parametric survival analysis and extended methods 
of the non-parametric Kaplan-Meier estimates to regression type arguments for life-table 
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analysis was performed by David Cox in 1972 (Collect, 1972). The Cox-PH is the semi-
parametric prediction of survival time by making no assumptions about the baseline 
hazard of individuals and only assuming that the hazard functions of different individuals 
remain proportional and constant over time.  
The hazard function Cox PH is given by equation 6.24, 
   ̂ ( )    ( )    ( ̂ 𝑥    ̂ 𝑥      ̂ 𝑥  )  (6.24), 
where ho(t) is the baseline hazard function, βs are regression coefficients, and xi denotes 
an individual covariate vector (explanatory variable).The survival function as a result of 
the Cox PH performance is given by equation 6.25: 
     ( )      ( ∫   (𝑢)
 
 
 𝑢 (6.25). 
The influence of variables is to shift the baseline survivor function that is given by 
equation 6.26: 
  ( )    ( )    (𝑥  )     (6.26) 
The following Table 6.4 represents the variables’ names and their interactions used in the 
Cox PH regression model respectively to each race and both races together. 
Table 6.4 Data Set Variables 
Gender;( x1) Gender of patient cancer 
Age ; (x2) Age in year 
Sequence-number(x3)       Every record has a sequence number variable that indicates 
its chronological position. 
Tumor(x4)       Size of malignant tumor in cm 
Stage(x5)       Development level of cancer tumor in organ 
Race(x6)       African American, Whites 
Treat(x7) Procedure of treatment; Surgery, Radiotherapy or both 
before and after surgery  
   
 
111 
 
To obtain the survival function of the Cox PH model respectively to each race and both 
races together, a regression model of survival time as a response variable and attribute 
variables is achieved.  
 
 African American 
The fitted survival function is given by equation 6.27 
  ̂  ( )      ( ∫       (      𝑥        𝑥         𝑥   𝑥          𝑥   
 
 
       𝑥             𝑥  𝑥         𝑥  𝑥         𝑥  𝑥  𝑥        𝑥   
      𝑥  )  𝑢  (6.27) 
and the corresponding estimate of the hazard function (6.28) 
 ̂  ( )  ∫       (      𝑥        𝑥        𝑥   𝑥          𝑥         𝑥     
 
 
        𝑥  𝑥         𝑥  𝑥         𝑥  𝑥  𝑥        𝑥          𝑥  )  𝑢  (6.28) 
Table 6.5 displays an analysis of the maximum likelihood estimation of parameters of the 
Cox PH model for African-American pancreatic cancer patients. 
Table 6.5 Analysis of Maximum Likelihood Estimation 
Parameter                       Estimate       Error             Chi-Square     P-Value 
 
 Gender  1.19576 0.5393 4.9782 0.0257     
 Age 0.05078 0.01321 14.7850 0 .0001     
 Gender*Age -0.01864 0.00784 5.6501 0 .0175      
 Sequence-Number -0.13685 0.03299 17.2122 < .0001      
Tumor 0.51248 0.16316 9.8658 0 .0017      
Tumor*gender -0.34063 0.09698 12.3379 0 .0004     
 Age*Tumor - 0.00697 0.00273 8.6545 0 .0033      
Gender*Age*Tumor 0.00469 .00140 11.1777 0.0008 
Stage 0.30197 0.02112 204.4655 < .0001     
 Treat  -0.19963 0.02898 47.4608 < .0001     
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As shown in Table 6.6, the model fits under the null hypothesis βi =   where  =     
Table 6.6 Evaluation the Best Fitted Regression Model of Cox PH 
       Test Chi-Square  DF P-value 
Likelihood Ratio 
Score 
Wald 
527.9261 
509.3716 
496.0307 
10 
10 
10 
<.0001 
<.0001 
<.0001 
          
 Residual Analysis  
 A graph of survival functions of Cox PH and Pareto is shown in Figure 6.9, 
which shows that the difference between these curves is obvious. 
 
Figure 6.9 Survival Functions of Cox PH and Pareto 
 
To evaluate the difference between survival models of these two functions, a residual 
analysis is achieved. The result shows that the mean residual is -.03460, with a standard 
deviation of 0.02180 and a residual and mean square error (MSE) of 0.00166. 
 
 Whites 
The fitted survival function in the Cox PH model is given by equation (6.29) 
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 ̂  ( )      ( ∫      (      𝑥        𝑥          𝑥   𝑥          𝑥   
 
 
     𝑥  𝑥          𝑥         𝑥  𝑥        𝑥  𝑥          𝑥  𝑥        𝑥   
      𝑥  )  𝑢  (6.29), 
and the corresponding estimate of the hazard function is given by equation 6.30: 
 ̂  ( )  ∫       (      𝑥        𝑥         𝑥   𝑥          𝑥   
 
 
     𝑥  𝑥         𝑥         𝑥  𝑥        𝑥  𝑥         𝑥  𝑥        𝑥   
      𝑥  )  𝑢           (6.30) 
 Table 6.7 shows the analysis of maximum likelihood estimation of parameters of the 
Cox PH model results for white pancreatic cancer patients. 
   Table 6.7 Analysis of Maximum Likelihood Estimation 
Parameter                           Estimate       Error               Chi-Square    P-Value 
 
 Gender  -0.34588 0.10087 11.7580 0.0006    
 Age 0.01227 0.00259 22.4053 < .0001     
 Gender*Age 0.00460 0.00143 10.2919 0 .0013      
 Sequence-Number -0.46528 0.07929 34.4385 < .0001      
Age*Sequence-Number 0.00534 0.00106 25.5786 < .0001 
Tumor  -0.07769 0.01735 20.0459 < .0001    
 Age*Tumor - 0.00138 0.000248 30.8359 < .0001     
Stage 0.35010 0.00795 1940.3241 < .0001     
Stage*Treatment -0.02749 0.01348 4.1613 0.0457 
Tumor*Treatment 0.00889 0.00445 3.9918 < .0001 
 Treatment  -0.19963 0.02898 47.4608 < .0001     
 
The results of fitting the model under the null hypothesis βi = 0, where    …   , it has 
shown in the table 6.8.      
Table 6.8 Evaluation the Best-Fitted Regression Model of Cox PH 
       Test Chi-Square  DF P-value 
Likelihood Ratio 
Score 
Wald 
4390.8443 
4259.3266 
4126.2505 
10 
10 
10 
<.0001 
<.0001 
<.0001 
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Residual Analysis 
Figure 6.10 displays a graph of the survival function of Cox PH and Pareto, 
indicating that a difference between these two functions is recognizable. A performance 
of residual analysis of the difference between the probabilistic function of survival time 
and the Cox PH survival function shows that the mean residual is -0.02527, with a 
standard deviation of 0.02153 and a residual and mean square error (MSE) of 0.00120.  
 
Figure 6.10 Survival Functions Cox PH Pareto 
 
 Both Races 
The fitted survival function is given by equation 6.31, 
 ̂  ( )      ( ∫      (      𝑥        𝑥        𝑥   𝑥          𝑥   
 
 
      𝑥  𝑥         𝑥         𝑥  𝑥        𝑥        𝑥        𝑥  )  𝑢   (6.31), 
and the corresponding estimation of the hazard function is given by equation (6.32) 
 ̂  ( )  ∫       (      𝑥        𝑥        𝑥   𝑥          𝑥         𝑥  𝑥   
 
 
      𝑥         𝑥  𝑥        𝑥         𝑥        𝑥  )  𝑢                        (6.32). 
The result of maximum likelihood estimation of the parameters of the Cox PH model is 
shown in Table 6.9 for both races of pancreatic cancer patients. 
S(t)
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0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 190
SUV-Cox PH - - -   SUV-Pareto ---- Whites
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Table 6.9 Analysis of Maximum Likelihood Estimation 
Parameter                     Estimate        Error              Chi-Square    P-
Value 
Gender -0.38571 0.09305 17.1827 < .0001 
Age 0.01193 0.00241 24.5039 < .0001 
Gender*Age 0.00494 0.00133 13.8001 0.0002 
Sequence-Number -0.44198 0.07446 35.2291 < .0001 
Age*Sequence-
Number 
0.00497 0.000999 24.7053 < .0001 
Tumor -0.06840 0.01593 18.4427 < .0001 
Age*Tumor - 0.00123 0.000230 28.5347 < .0001 
Stage 0.34162 0.00730 2190.7501 < .0001 
Race -0.18670 0.00971 369.7524 < .0001 
Treatment -0.18670 0.00971 369.7524 < .0001 
 
Table 6.10 displays the model fits under the null hypothesis βi=0 where i=1… k. 
 
Table 6.10 Evaluation of the Best-Fitted Regression Model of Cox PH 
       Test Chi-Square  DF P-value 
Likelihood Ratio 
Score 
Wald 
4885.7863 
4701.2661 
4587.5365 
10 
10 
10 
<.0001 
<.0001 
<.0001 
 
                
 Residual Analysis 
Figure 6.11 displays a graph of survival function of Cox PH and Pareto. The 
difference between these curves is clear. Thus, a residual analysis has been performed 
between the Pareto survival function and Cox PH survival function. The result shows that 
the mean residual is 0.24474, with a standard deviation of 0.02129 and a residual and 
mean square error (MSE) of 0.00105.  
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Figure 6.11 Survival Functions of Cox PH and Pareto 
 Summary 
It has been shown that the Cox PH models for each race and both races together 
are different. The comparison of the Cox PH survival function and Pareto survival 
function shows that the Cox PH function over-estimates the survival time with respect to 
each race and both races together.   
 
6.7  Comparson of Survival Functions 
Comparsion results of Kaplan Meier, kernel density, and Cox PH with parametric 
survival anlysis (Pareto) by using SEER data for pancreatic cancer are displayed in Table 
6.11. Also, a ranked evaluation is shown in Table 6.11 by using the lowest mean of 
standard error (Young & Tsokos, 2010).  
As can be seen in Table 6.11, all three survival models performed well with respect to 
individual races and both races together. However, the edge goes to the kernel density 
estimator function (KER) in terms of having a minimum mean of standard error (MSE). 
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Moreover, survival Cox PH stays the second-ranked evaluation, and finally the Kaplan 
Meier function is third.   
Table 6.11 Residual Analysis and Ranking KER, KM and Cox PH with Parametric Function 
Race Kernel vs. parametric KM vs. Parametric Cox PH vs. Pareto 
AA 
Mean- Res= 0.03024 
Std-Res=  0.02274 
MSE=  0.00143 
Mean- Res=  -0.05015 
Std-Res=  0.07384 
MSE=  0.00796 
Mean- Res=  -0.03460 
Std-Res= 0.02180 
MSE=  0.00166 
Rank 1 3 2 
Whites  
Mean- Res= 0.02495 
Std-Res= 0.01837 
MSE= 0.00096 
Mean- Res= -0.03672 
Std-Res= 0.05732 
MSE= 0.00463 
Mean- Res= -0.02527 
Std-Res= 0.02153 
MSE= 0.00120 
Rank 1 3 2 
Both 
Races 
Mean- Res= 0.02555 
Std-Res= 0.01891 
MSE= 0.00101 
Mean- Res=- 0.03859 
Std-Res= 0.05958 
MSE= 0.00504 
Mean- Res= -0.24474 
Std-Res= 0.01229 
MSE= 0.00105 
Rank 1 3 2 
 
 
6.8 Conclusion and Contribution 
In this study, we initiated that  
 There was no significant difference between the true mean survival times of 
genders. 
 There was significant difference between the true mean survival times of white 
males and African American males. 
 There was no significant difference between the true mean survival times of white 
males and other races males. 
 There was significant difference between the true mean survival times of other 
races males and African American males. 
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 There was significant difference between the true mean survival times of white 
females and African American females. 
 There was no significant difference between the true mean survival times of white 
females and other races females. 
  There was significant difference between the true mean survival times of other 
races females and African American females. 
   However, there was a significant difference between the true mean of survival 
time African American pancreatic cancer patients and white pancreatic cancer 
patients.  
   There was a significant difference between the true mean of survival time 
African American pancreatic cancer patients and other races pancreatic cancer 
patients.  
 There was not a significant difference between the true mean of survival time 
white pancreatic cancer patients and other races pancreatic cancer patients.  
We instructed the Seers data base as showing the diagram and perform statistical analysis 
in term in the difference between races and proceed to perform 
 a) Parametric statistical analysis 
 b) Kernel density 
 c)  Nonparametric survival analysis (Kaplan Meier) and Cox PH. 
 Lastly, this present study contained four parallel performing Functions on survival 
analysis with SEER pancreatic cancer data. A comparison survival function of kernel, 
Kaplan Meier, and Cox PH with the parametric fitted model Pareto distribution (PD) was 
performed with respect to African Americans, whites, and both races together. A ranked 
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evaluation of these functions shows that the kernel density gives the best result when a 
probabilistic parametric model cannot be accomplished. 
In addition, the Cox PH model is ranked second, and finally the Kaplan Meier 
model comes in third. These results were consistent with respect to each race and both 
races together. Finally, as the sample of the survival times increases, all of the survival 
functions converge to give similar results. 
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Chapter 7: 
Conclusions and Future Research 
 
7.1 Conclusions and Contribution 
In this present study we applied various statistical approaches to modeling and predicting 
the optimism levels with attribute variables for delay, education, age, and for African-
American and white races of breast cancer patients. In addition, the statistical models for 
optimism levels as a function of age are unlike with respect to race.  It was found that the 
level of optimism had an indirect correlation with delay and a direct association with 
education. It was well-known the parametric characterize behavior of optimism levels for 
each race. 
  Furthermore, we found that personality type C did not show any difference in the 
symptoms of breast cancer and healthy control groups. Moreover, it was established that 
age did not affect the association between cancer and State-Trait personality. However, in 
the state of anxiety, the mean of T-anger-In/Out, Anger/Control, T-Anger/ Reaction, and 
Temp was different between breast cancer patients and healthy groups in the age group of 
50 and less. Moreover, in the age group of over 50, the mean of curiosity and Anger/Out 
for breast cancer patients was significantly less than control groups and the state-traits of 
Anger/in and Anger/Control were significantly higher. In state R/ED, the mean of the 
control group and the healthy group were significantly different except in the case of 
N/H. finally, breast cancer patients had more anxiety than the healthy group. In coping 
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states, cancer patients exhibited less in the following categories: problem-focused, 
wishing thinking, seek social support, blamed self, avoidance, and blamed others, and 
more in count your blessings and religiosity than the healthy groups. 
For deadly pancreatic cancer, we showed that the mean of tumor size is 
significantly different between females and males. However, we found there was no 
difference between African Americans and whites for tumor size mean for male 
pancreatic cancer patients. Furthermore, we investigated that the mean of cancer tumor 
size is a mathematical function of age. Moreover, a positive correlation was established 
between age and the mean of tumor size for pancreatic cancer patients by using the 
differential equation T`(a) and residual analysis. 
 Finally, to identify the best survival function by ranking if we are not able to 
classify the parametric function. Thus, a comparison survival function of Kernel, Kaplan 
Meier, and Cox PH with a parametric fitted model Pareto distribution (PD) was 
performed with respect to African Americans, whites, and both races together. Ranking 
evaluation of these functions shows that the kernel density gives the best result when a 
probabilistic parametric model cannot be accomplished. 
In addition, the Cox PH model is the second best-fitted model, then finally the 
Kaplan Meier Model, the results of which were consistent with respect to each race and 
both races together.  
 
7.2 Future Research 
 
In future, we can develop several estimates models of optimism based on several 
attributed variables to identify the maximum surface response of optimism for 99% and 
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95% confidence intervals. In survival analysis of pancreatic cancer justify on Bayesian 
analysis which is more powerful than the parametric survival analysis. Furthermore, we 
can develop statistical models of regional mortality analysis on pancreatic cancer patients 
and compare the results .we can proceed statistical mortality pancreatic cancer by using 
time series methodology. 
Future justification of the models may be conducted by the SEER pancreatic cancer data 
collection could provide more relevant information on pancreatic cancer such as stages, 
surgery, chemo theory, and number of lymph nodes involved,… by providing more 
compressive understanding of pancreatic cancer in survival analysis. 
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Revised Life Orientation Tests (LOT-R) 
 
 
